Available Full-Text Publications

574 items found

Abi-Dargham A;Rodenhiser J;Printz D;Zea-Ponce Y;Gil R;Kegeles LS;Weiss R;Cooper TB;Mann JJ;Van Heertum RL;Gorman JM;Laruelle M;    Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.  Proceedings of the National Academy of Sciences of the United States of America.  2000;97(14):8104-8109      

Adelstein JS;Shehzad Z;Mennes M;Deyoung CG;Zuo XN;Kelly C;Margulies DS;Bloomfield A;Gray JR;Castellanos FX;Milham MP;    Personality is reflected in the brain's intrinsic functional architecture.  PLoS ONE.  2011;6(11):e27633      

Alexopoulos GS;Kiosses DN;Choi SJ;Murphy CF;Lim KO;    Frontal white matter microstructure and treatment response of late-life depression: a preliminary study.  American Journal of Psychiatry.  2002;159(11):1929-1932      

Alexopoulos GS;Murphy CF;Gunning-Dixon FM;Latoussakis V;Kanellopoulos D;Klimstra S;Lim KO;Hoptman MJ;    Microstructural white matter abnormalities and remission of geriatric depression.  American Journal of Psychiatry.  2008;165(2):238-244      

Alldred MJ;Che S;Ginsberg SD;    Terminal continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain.  International Journal of Molecular Sciences.  2008;9(11):2091-2104      

Alper KR;Prichep LS;Kowalik S;Rosenthal MS;John ER;    Persistent QEEG abnormality in crack cocaine users at 6 months of drug abstinence.  Neuropsychopharmacology.  1998;19(1):1-9      

Alphs L;Anand R;Islam MZ;Meltzer HY;Kane JM;Krishnan R;Green AI;Potkin S;Chouinard G;Lindenmayer JP;Kerwin R;    The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients.  Schizophrenia Bulletin.  2004;30(3):577-586      

Amaral DG;Scharfman HE;Lavenex P;    The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies).  Progress in Brain Research.  2007;163:3-22, 788-790      

Amering M;Stastny P;Hopper K;    Psychiatric advance directives: qualitative study of informed deliberations by mental health service users.  British Journal of Psychiatry.  2005;186(3):247-252      

Andorfer C;Acker CM;Kress Y;Hof PR;Duff K;Davies P;    Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.  Journal of Neuroscience.  2005;25(22):5446-5454      

Anney R;Klei L;Pinto D;Regan R;Conroy J;Magalhaes TR;Correia C;Abrahams BS;Sykes N;Pagnamenta AT;Almeida J;Bacchelli E;Bailey AJ;Baird G;Battaglia A;Berney T;Bolshakova N;Bolte S;Bolton PF;Bourgeron T;Brennan S;Brian J;Carson AR;Casallo G;Casey J;Chu SH;Cochrane L;Corsello C;Crawford EL;Crossett A;Dawson G;de JM;Delorme R;Drmic I;Duketis E;Duque F;Estes A;Farrar P;Fernandez BA;Folstein SE;Fombonne E;Freitag CM;Gilbert J;Gillberg C;Glessner JT;Goldberg J;Green J;Guter SJ;Hakonarson H;Heron EA;Hill M;Holt R;Howe JL;Hughes G;Hus V;Igliozzi R;Kim C;Klauck SM;Kolevzon A;Korvatska O;Kustanovich V;Lajonchere CM;Lamb JA;Laskawiec M;Leboyer M;Le CA;Leventhal BL;Lionel AC;Liu XQ;Lord C;Lotspeich L;Lund SC;Maestrini E;Mahoney W;Mantoulan C;Marshall CR;McConachie H;McDougle CJ;McGrath J;McMahon WM;Melhem NM;Merikangas A;Migita O;Minshew NJ;Mirza GK;Munson J;Nelson SF;Noakes C;Noor A;Nygren G;Oliveira G;Papanikolaou K;Parr JR;Parrini B;Paton T;Pickles A;Piven J;Posey DJ;Poustka A;Poustka F;Prasad A;Ragoussis J;Renshaw K;Rickaby J;Roberts W;Roeder K;Roge B;Rutter ML;Bierut LJ;Rice JP;Salt J;Sansom K;Sato D;Segurado R;Senman L;Shah N;Sheffield VC;Soorya L;Sousa I;Stoppioni V;Strawbridge C;Tancredi R;Tansey K;Thiruvahindrapduram B;Thompson AP;Thomson S;Tryfon A;Tsiantis J;Van EH;Vincent JB;Volkmar F;Wallace S;Wang K;Wang Z;Wassink TH;Wing K;Wittemeyer K;Wood S;Yaspan BL;Zurawiecki D;Zwaigenbaum L;Betancur C;Buxbaum JD;Cantor RM;Cook EH;Coon H;Cuccaro ML;Gallagher L;Geschwind DH;Gill M;Haines JL;Miller J;Monaco AP;Nurnberger JI;Paterson AD;Pericak-Vance MA;Schellenberg GD;Scherer SW;Sutcliffe JS;Szatmari P;Vicente AM;Vieland VJ;Wijsman EM;Devlin B;Ennis S;Hallmayer J;    (non-copyrighted -attachment )
A genome-wide scan for common alleles affecting risk for autism.  Human Molecular Genetics.  2010;19(20):4072-4082      

Antonius D;    Insight and aggression in schizophrenia [letter].  American Journal of Psychiatry.  2005;162(11):2195      

Antonova I;Arancio O;Trillat AC;Wang HG;Zablow L;Udo H;Kandel ER;Hawkins RD;    Rapid increase in clusters of presynaptic proteins at onset of long-lasting potentiation.  Science.  2001;294(5546):1547-1550      

Arancio O;Antonova I;Gambaryan S;Lohmann SM;Wood JS;Lawrence DS;Hawkins RD;    Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation.  Journal of Neuroscience.  2001;21(1):143-149      

Arancio O;Zhang HP;Chen X;Lin C;Trinchese F;Puzzo D;Liu S;Hegde A;Yan SF;Stern A;Luddy JS;Lue LF;Walker DG;Roher A;Buttini M;Mucke L;Li W;Schmidt AM;Kindy M;Hyslop PA;Stern DM;Du Yan SS;    RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice.  EMBO Journal.  2004;23(20):4096-4105      

Ardekani BA;Bappal A;D'angelo D;Ashtari M;Lencz T;Szeszko PR;Butler PD;Javitt DC;Lim KO;Hrabe J;Nierenberg J;Branch CA;Hoptman MJ;    Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia.  Neuroreport.  2005;16(13):1455-1459      

Ardekani BA;Guckemus S;Bachman A;Hoptman MJ;Wojtaszek M;Nierenberg J;    Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans.  Journal of Neuroscience Methods.  2005;142(1):67-76      

Ardekani BA;Tabesh A;Sevy S;Robinson DG;Bilder RM;Szeszko PR;    Diffusion tensor imaging reliably differentiates patients with schizophrenia from healthy volunteers.  Human Brain Mapping.  2011;32(1):1-9      

Ashtari M;Cottone J;Ardekani BA;Cervellione K;Szeszko PR;Wu J;Chen S;Kumra S;    Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fiber tractography.  Archives of General Psychiatry.  2007;64(11):1270-1280      

Bai Y;Markham K;Chen F;Weerasekera R;Watts J;Horne P;Wakutani Y;Mathews PM;Fraser PE;Westaway D;St George-Hyslop P;Schmitt-Ulms G;    The in vivo brain interactome of the amyloid precursor protein.  Molecular & Cellular Proteomics.  2008;7(1):15-34      

Balla A;Koneru R;Smiley J;Sershen H;Javitt DC;    Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release.  Neuropsychopharmacology.  2001;25(2):157-164      

Balla A;Sershen H;Serra M;Koneru R;Javitt DC;    Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.  Neuropsychopharmacology.  2003;28(1):34-44      

Barnes DC;Chapuis J;Chaudhury D;Wilson DA;    Odor fear conditioning modifies piriform cortex local field potentials both during conditioning and during post-conditioning sleep.  PLoS ONE.  2011;6(3):e18130      

Bartlett EJ;Brodie JD;Simkowitz P;Schlosser R;Dewey SL;Lindenmayer JP;Rusinek H;Wolkin A;Cancro R;Schiffer W;    Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.  American Journal of Psychiatry.  1998;155(3):337-343      

Bartus RT;Emerich D;Snodgrass-Belt P;Fu K;Salzberg-Brenhouse H;Lafreniere D;Novak L;Lo ES;Cooper T;Basile AS;    A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease.  Journal of Pharmacology & Experimental Therapeutics.  2004;310(2):828-835      

Basavarajappa BS;    Critical enzymes involved in endocannabinoid metabolism.  Protein & Peptide Letters.  2007;14(3):237-246      

Basavarajappa BS;    Neuropharmacology of the endocannabinoid signaling system: molecular mechanisms, biological actions and synaptic plasticity.  Current Neuropharmacology.  2007;5(2):81-97      

Basavarajappa BS;    The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.  Mini-Reviews in Medicinal Chemistry.  2007;7(8):769-779      

Basavarajappa BS;Hungund BL;    Role of the endocannabinoid system in the development of tolerance to alcohol.  Alcohol and Alcoholism.  2005;40(1):15-24      

Baslow MH;    The vertebrate brain, evidence of its modular organization and operating system: insights into the brain's basic units of structure, function, and operation and how they influence neuronal signaling and behavior.  Frontiers in Behavioral Neuroscience.  2011;5:5      

Baslow MH;    The languages of neurons: an analysis of coding mechanisms by which neurons communicate, learn and store information.  Entropy.  2009;11(4):782-797      

Baslow MH;    (non-copyrighted -attachment )
The nature of neuronal words and language.  Natural Science.  2010;2(3):205-211      

Battaglia J;Robinson DG;Citrome L;    The treatment of acute agitation in schizophrenia.  CNS Spectrums.  2007;12(8 Suppl 11):1-13      

Bertollo DN;Alexander MJ;Shinn M;Aybar JB;    Innovations: clinical computing: an audio computer-assisted self-interviewing system for research and screening in public mental health settings.  Psychiatric Services.  2007;58(6):743-745      

Bilder RM;    Neuropsychology for the 21st century: methodological advances.  CNS Spectrums.  2002;7(4):273-273      

Bilder RM;    Neurocognitive impairment in schizophrenia and how it affects treatment options. [Review].  Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.  1997;42(3):255-264      

Bilder RM;Goldman RS;Robinson D;Reiter G;Bell L;Bates JA;Pappadopulos E;Willson DF;Alvir JMJ;Woerner MG;Geisler S;Kane JM;Lieberman JA;    Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates.  American Journal of Psychiatry.  2000;157(4):549-559      

Bilder RM;Goldman RS;Volavka J;Czobor P;Hoptman M;Sheitman B;Lindenmayer JP;Citrome L;McEvoy J;Kunz M;Chakos M;Cooper TB;Horowitz TL;Lieberman JA;    Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder [Comment in: Am J Psychiatry. 2002 Dec;159(12):2118; author reply 2118-9].  American Journal of Psychiatry.  2002;159(6):1018-1028      

Bilder RM;Volavka J;Lachman HM;Grace AA;    The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.  Neuropsychopharmacology.  2004;29(11):1943-1961      

Boland B;Kumar A;Lee S;Platt FM;Wegiel J;Yu WH;Nixon RA;    Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease.  Journal of Neuroscience.  2008;28(27):6926-6937      

Bollimunta A;Chen Y;Schroeder CE;Ding M;    Neuronal mechanisms of cortical alpha oscillations in awake-behaving macaques.  Journal of Neuroscience.  2008;28(40):9976-9988      

Bonanomi D;Menegon A;Miccio A;Ferrari G;Corradi A;Kao HT;Benfenati F;Valtorta F;    Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons.  Journal of Neuroscience.  2005;25(32):7299-7308      

Boroojerdi B;Bushara KO;Corwell B;Immisch I;Battaglia F;Muellbacher W;Cohen LG;    Enhanced excitability of the human visual cortex induced by short-term light deprivation.  Cerebral Cortex.  2000;10(5):529-534      

Bourgeois M;Swendsen J;Young F;Amador X;Pini S;Cassano GB;Lindenmayer JP;Hsu C;Alphs L;Meltzer HY;The InterSePT Study Group;    Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial.  American Journal of Psychiatry.  2004;161(8):1494-1496      

Bowers MB;Kantrowitz JT;    Elevated plasma dopamine metabolites in cannabis psychosis.  American Journal of Psychiatry.  2007;164(10):1615-1616      

Boyarsky BK;Dilts S;Frances RJ;Frosch WA;Galanter M;Levin F;Lewis C;Loomis E;Menninger JA;Nace EP;Suchinsky R;Sullivan M;Tamerin J;Westermeyer J;Wolkoff D;Ziedonis D;Group for the Advancement of Psychiatry CoA;    Responsibility and choice in addiction.  Psychiatric Services.  2002;53(6):707-713      

Brent D;Greenhill LL;Compton S;Emslie G;Wells K;Walkup J;Vitiello B;Bukstein O;Stanley B;Posner K;Kennard BD;Cwik M;Wagner A;Coffey B;March J;Riddle M;Goldstein T;Curry J;Barnett S;Capasso L;Zelazny J;Hughes J;Shen S;Gugga S;Turner JB;    The Treatment of Adolescent Suicide Attempters Study (TASA): predictors of suicidal events in an open treatment trial.  Journal of the American Academy of Child & Adolescent Psychiatry.  2009;48(10):987-996      

Brown AS;Gewirtz G;Harkavy-Friedman J;Cooper T;Brebion G;Amador XF;Malaspina D;Gorman JM;    Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.  Neuropsychopharmacology.  1997;17(5):317-325      

Brown LS;Kritz S;Goldsmith RJ;Bini EJ;Robinson J;Alderson D;Rotrosen J;    Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs.  Public Health Reports.  2007;122(4):441-451      

Brown LS;Kritz S;Muhammad A;Bini EJ;Goldsmith RJ;Robinson J;Alderson D;Hasin DS;Rotrosen J;    Disparities in health services for HIV/AIDS, hepatitis C virus, and sexually transmitted infections: role of substance abuse treatment programs.  Journal of Addiction Medicine.  2009;3(2):95-102      

Brown LS;Kritz SA;Goldsmith RJ;Bini EJ;Rotrosen J;Baker S;Robinson J;McAuliffe P;    Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network.  Journal of Substance Abuse Treatment.  2006;30(4):315-321      

Bruehl H;Sweat V;Tirsi A;Shah B;Convit A;    Obese adolescents with type 2 diabetes mellitus have hippocampal and frontal lobe volume reductions.  Neuroscience & Medicine.  2011;2(1):34-42      

Buchanan RW;Freedman R;Javitt DC;Abi-Dargham A;Lieberman JA;    Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.  Schizophrenia Bulletin.  2007;33(5):1120-1130      

Buchanan RW;Javitt DC;Marder SR;Schooler NR;Gold JM;McMahon RP;Heresco-Levy U;Carpenter WT;    The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.  American Journal of Psychiatry.  2007;164(10):1593-1602      

Burns M;Gaynor K;Olm V;Mercken M;LaFrancois J;Wang L;Mathews PM;Noble W;Matsuoka Y;Duff K;    Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo.  Journal of Neuroscience.  2003;23(13):5645-5649      

Bush DE;Caparosa EM;Gekker A;Ledoux J;    (non-copyrighted -attachment )
Beta-adrenergic receptors in the lateral nucleus of the amygdala contribute to the acquisition but not the consolidation of auditory fear conditioning.  Frontiers in Behavioral Neuroscience.  2010;4:154      

Butler PD;Hoptman MJ;Nierenberg J;Foxe JJ;Javitt DC;Lim KO;    Visual white matter integrity in schizophrenia.  American Journal of Psychiatry.  2006;163(11):2011-2013      

Butler PD;Javitt DC;    Early-stage visual processing deficits in schizophrenia.  Current Opinion in Psychiatry.  2005;18(2):151-157      

Butler PD;Martinez A;Foxe JJ;Kim D;Zemon V;Silipo G;Mahoney J;Shpaner M;Jalbrzikowski M;Javitt DC;    Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments.  Brain.  2007;130(Pt 2):417-430      

Butler PD;Martinez A;Foxe JJ;Kim D;Zemon V;Silipo G;Mahoney J;Shpaner M;Jalbrzikowski M;Javitt DC;    Reply: A few remarks on assessing magnocellular sensitivity in patients with schizophrenia.  Brain.  2007;130(11):e84      

Butler PD;Schechter I;Zemon V;Schwartz SG;Greenstein VC;Gordon J;Schroeder CE;Javitt DC;    (non-copyrighted -attachment )
Early-stage vision and schizophrenia: Dr. Butler and colleagues reply [letter].  American Journal of Psychiatry.  2002;159(4):678-679      

Butler PD;Schechter I;Zemon V;Schwartz SG;Greenstein VC;Gordon J;Schroeder CE;Javitt DC;    Dysfunction of early-stage visual processing in schizophrenia [Comment in: Am J Psychiatry. 2002 Apr;159(4):678; author reply 678-9].  American Journal of Psychiatry.  2001;158(7):1126-1133      

Butler PD;Silverstein SM;Dakin SC;    Visual perception and its impairment in schizophrenia.  Biological Psychiatry.  2008;64(1):40-47      

Butler PD;Zemon V;Schechter I;Saperstein AM;Hoptman MJ;Lim KO;Revheim N;Silipo G;Javitt DC;    Early-stage visual processing and cortical amplification deficits in schizophrenia.  Archives of General Psychiatry.  2005;62(5):495-504      

Calingasan NY;Park LC;Calo LL;Trifiletti RR;Gandy SE;Gibson GE;    Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism.  American Journal of Pathology.  1998;153(2):599-610      

Campbell BK;Fuller BE;Lee ES;Tillotson C;Woelfel T;Jenkins L;Robinson J;Booth RE;McCarty D;    Facilitating outpatient treatment entry following detoxification for injection drug use: a multisite test of three interventions.  Psychology of Addictive Behaviors.  2009;23(2):260-270      

Cancro R;    Book review: Ethics, Culture, and Psychiatry: International Perspectives.  American Journal of Psychiatry.  2003;160(9):1712      

Cancro R;    Book review: The Difficult-to-Treat Psychiatric Patient.  American Journal of Psychiatry.  2003;160(1):201      

Cancro R;    Book review: Psychological Treatment of Bipolar Disorder.  American Journal of Psychiatry.  2005;162(3):641-642      

Cancro R;    Book review: The Prehistory of the Mind: The Cognitive Origins of Art, Religion and Science.  American Journal of Psychiatry.  1998;155(12):1797      

Cancro R;    Book review: Delayed Posttraumatic Stress Disorders From Infancy: The Two Trauma Mechanism.  American Journal of Psychiatry.  1998;155(5):701-702      

Cancro R;    Book review: Neurology for Non-Neurologists, 3rd ed..  American Journal of Psychiatry.  1998;155(4):569-570      

Cancro R;    Book review: Cambridge Handbook of Psychology, Health and Medicine.  American Journal of Psychiatry.  1999;156(7):1112      

Cancro R;    The introduction of neuroleptics: A psychiatric revolution.  Psychiatric Services.  2000;51(3):333-335      

Cancro R;    Book review: Psychiatric Drugs.  American Journal of Psychiatry.  2001;158(2):331      

Cancro R;    Book review: Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care.  American Journal of Psychiatry.  2001;158(2):331      

Cancro R;    Book review: Drug Effects on Psychomotor Performance.  American Journal of Psychiatry.  2002;159(1):168      

Cancro R;Roy E;Chabot R;Prichep L;    Subtyping of psychiatric disorders: implications for drug development.  Dialogues in Clinical Neuroscience.  2002;4(4):329-335      

Capell A;Grunberg J;Pesold B;Diehlmann A;Citron M;Nixon R;Beyreuther K;Selkoe DJ;Haass C;    The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex.  Journal of Biological Chemistry.  1998;273(6):3205-3211      

Carey RM;Verhagen JV;Wesson DW;Pirez N;Wachowiak M;    Temporal structure of receptor neuron input to the olfactory bulb imaged in behaving rats.  Journal of Neurophysiology.  2009;101(2):1073-1088      

Carmichael JD;Danoff A;Milani D;Roubenoff R;Lesser ML;Livote E;Reitz RE;Ferris S;Kleinberg DL;    GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.  Clinical Endocrinology.  2006;65(2):169-177      

Case BG;Olfson M;Marcus SC;Siegel C;    Trends in the inpatient mental health treatment of children and adolescents in US community hospitals between 1990 and 2000.  Archives of General Psychiatry.  2007;64(1):89-96      

Cataldo AM;Barnett JL;Pieroni C;Nixon RA;    Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.  Journal of Neuroscience.  1997;17(16):6142-6151      

Cataldo AM;Mathews PM;Boiteau AB;Hassinger LC;Peterhoff CM;Jiang Y;Mullaney K;Neve RL;Gruenberg J;Nixon RA;    Down syndrome fibroblast model of Alzheimer-related endosome pathology. Accelerated endocytosis promotes late endocytic defects.  American Journal of Pathology.  2008;173(2):370-384      

Cataldo AM;Petanceska S;Peterhoff CM;Terio NB;Epstein CJ;Villar A;Carlson EJ;Staufenbiel M;Nixon RA;    App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.  Journal of Neuroscience.  2003;23(17):6788-6792      

Cataldo AM;Peterhoff CM;Troncosco JC;GomezIsla T;Hyman BT;Nixon RA;    Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome - Differential effects of APOE genotype and presenilin mutations.  American Journal of Pathology.  2000;157(1):277-286      

Chabot RJ;di Michele F;Prichep L;John ER;    The clinical role of computerized EEG in the evaluation and treatment of learning and attention disorders in children and adolescents.  Journal of Neuropsychiatry & Clinical Neurosciences.  2001;13(2):171-186      

Chakraborty G;Saito M;Mao RF;Wang R;Vadasz C;Saito M;    Lithium blocks ethanol-induced modulation of protein kinases in the developing brain.  Biochemical & Biophysical Research Communications.  2008;367(3):597-602      

Chao HM;Kao HT;Porton B;    BDNF Val66Met variant and age of onset in schizophrenia.  American Journal of Medical Genetics Part B, Neuropsychiatric Genetics.  2008;147B(4):505-506      

Che S;Ginsberg SD;    Amplification of RNA transcripts using terminal continuation.  Laboratory Investigation.  2004;84(1):131-137      

Chen CM;Lakatos P;Shah AS;Mehta AD;Givre SJ;Javitt DC;Schroeder CE;    Functional anatomy and interaction of fast and slow visual pathways in Macaque monkeys.  Cerebral Cortex.  2007;17(7):1561-1569      

Chen F;Yang DS;Petanceska S;Yang A;Tandon A;Yu G;Rozmahel R;Ghiso J;Nishimura M;Zhang DM;Kawarai T;Levesque G;Mills J;Levesque L;Song YQ;Rogaeva E;Westaway D;Mount H;Gandy S;George-Hyslop P;Fraser PE;    Carboxyl-terminal fragments of Alzheimer beta -amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells.  Journal of Biological Chemistry.  2000;275(47):36794-36802      

Chen PX;Mathews PM;Good PJ;Rossier BC;Geering K;    Unusual degradation of alpha-beta complexes in Xenopus oocytes by beta-subunits of Xenopus gastric H-K-ATPase.  American Journal of Physiology.  1998;275(1 Pt 1):C139-C145      

Cheney DL;Uzunov D;Costa E;Guidotti A;    Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats.  Journal of Neuroscience.  1995;15(6):4641-4650      

Chishti MA;Yang DS;Janus C;Phinney AL;Horne P;Pearson J;Strome R;Zuker N;Loukides J;French J;Turner S;Lozza G;Grilli M;Kunicki S;Morissette C;Paquette J;Gervais F;Bergeron C;Fraser PE;Carlson GA;George-Hyslop PS;Westaway D;    Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.  Journal of Biological Chemistry.  2001;276(24):21562-21570      

Choi IY;Gruetter R;    Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from d-[1-C]glucose in the rat brain in vivo.  Journal of Neurochemistry.  2004;91(4):778-787      

Choi SI;Vidal R;Frangione B;Levy E;    Axonal transport of British and Danish amyloid peptides via secretory vesicles.  FASEB Journal.  2004;18(2):373-375      

Chou JC;    Review and update of the American Psychiatric Association practice guideline for bipolar disorder.  Primary Psychiatry.  2004;11(9):73-84      

Christensen BK;Bilder RM;    Dual cytoarchitectonic trends: an evolutionary model of frontal lobe functioning and its application to psychopathology.  Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.  2000;45(3):247-256      

Citrome L;   
Re: Treatment noncompliance with orally disintegrating olanzapine tablets.  Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.  2004;49(6):412-413      

Citrome L;    Antihostility effects of adjunctive divalproex [letter].  Psychiatric Services.  2004;55(9):1068-1069      

Citrome L;    Schizophrenia and valproate.  Psychopharmacology Bulletin.  2003;37(Suppl 2):74-88      

Citrome L;    Flexible oral olanzapine dosing in acutely agitated people is immediately effective in reducing symptoms [commentary].  Evidence-Based Mental Health.  2004;7(1):12      

Citrome L;    A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.  Neuropsychiatric Disease and Treatment.  2006;2(4):427-443      

Citrome L;    (non-copyrighted -attachment )
Citability of original research and reviews in journals and their sponsored supplements.  PLoS ONE.  2010;5(3):e9876      

Citrome L;Casey DE;Daniel DG;Wozniak P;Kochan LD;Tracy KA;    Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.  Psychiatric Services.  2004;55(3):290-294      

Citrome L;Jaffe A;Levine J;    Monotherapy versus polypharmacy for hospitalized psychiatric patients [letter].  American Journal of Psychiatry.  2005;162(3):631-633      

Citrome L;Jaffe A;Levine J;    Testing for diabetes [letter].  British Journal of Psychiatry.  2005;186(1):78      

Citrome L;Jaffe A;Levine J;    Datapoints: the ups and downs of dosing second-generation antipsychotics.  Psychiatric Services.  2007;58(1):11      

Citrome L;Jaffe A;Levine J;Allingham B;    Use of mood stabilizers among patients with schizophrenia, 1994-2001.  Psychiatric Services.  2002;53(10):1212      

Citrome L;Jaffe A;Levine J;Allingham B;Robinson J;    Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.  Psychiatric Services.  2004;55(9):1006-1013      

Citrome L;Jaffe A;Levine J;Martello D;    Incidence, prevalence, and surveillance for diabetes in New York State psychiatric hospitals, 1997-2004.  Psychiatric Services.  2006;57(8):1132-1139      

Citrome L;Jaffe A;Martello D;Allingham B;Levine J;    Did CATIE influence antipsychotic use?.  Psychiatric Services.  2008;59(5):476      

Citrome L;Levine J;Allingham B;    Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.  Psychiatric Services.  2000;51(5):634-638      

Citrome L;Volavka J;    Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement.  Diabetes Care.  2004;27(8):2087-2088      

Citrome L;Volavka J;Czobor P;Sheitman B;Lindenmayer JP;McEvoy J;Cooper TB;Chakos M;Lieberman JA;    Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.  Psychiatric Services.  2001;52(11):1510-1514      

Citrome LL;    Efficacy should drive atypical antipsychotic treatment [letter].  BMJ.  2003;326(7383):283      

Clark CM;DeCarli C;Mungas D;Chui HI;Higdon R;Nunez J;Fernandez H;Negron M;Manly J;Ferris S;Perez A;Torres M;Ewbank D;Glosser G;van BG;    Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals.  Archives of Neurology.  2005;62(5):774-778      

Cloitre M;    Effective psychotherapies for posttraumatic stress disorder: a review and critique.  CNS Spectrums.  2009;14(1 Suppl 1):32-43      

Coccaro EF;Kavoussi RJ;Cooper TB;Hauger RL;    Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.  Neuropsychopharmacology.  1996;15(6):595-607      

Coccaro EF;Kavoussi RJ;Cooper TB;Hauger RL;    Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.  American Journal of Psychiatry.  1997;154(10):1430-1435      

Coccaro EF;Kavoussi RJ;Hauger RL;Cooper TB;Ferris CF;    Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects.  Archives of General Psychiatry.  1998;55(8):708-714      

Cohen JI;Cazettes F;Convit A;    Abnormal cholesterol is associated with prefrontal white matter abnormalities among obese adults, a diffusion tensor imaging study.  Neuroradiology Journal.  2011;1(21):989-997      

Cohen JI;Yates KF;Duong M;Convit A;    Obesity, orbitofrontal structure and function are associated with food choice: a cross-sectional study.  BMJ Open.  2011;1(2):e000175      

Convit A;de Leon MJ;Tarshish C;De Santi S;Wells C;George A;Saint Louis LA;Rusinek H;    Hippocampal atrophy as detected by width of the temporal horn is greater in Alzheimer dementia than in nondementing cognitive impairment [comment].  American Journal of Neuroradiology.  1997;18(6):1193-1195      

Convit A;Wolf OT;Tarshish C;de Leon MJ;    Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly.  Proceedings of the National Academy of Sciences of the United States of America.  2003;100(4):2019-2022      

Coplan JD;Pine D;Papp L;Martinez J;Cooper T;Rosenblum LA;Gorman JM;    Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients.  Neuropsychopharmacology.  1995;13(1):65-73      

Coplan JD;Trost RC;Owens MJ;Cooper TB;Gorman JM;Nemeroff CB;Rosenblum LA;    Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions.  Archives of General Psychiatry.  1998;55(5):473-477      

Counts SE;He B;Che S;Ginsberg SD;Mufson EJ;    Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease.  Journal of Alzheimer's Disease.  2009;18(4):885-896      

Counts SE;He B;Che S;Ikonomovic MD;DeKosky ST;Ginsberg SD;Mufson EJ;    Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.  Archives of Neurology.  2007;64(12):1771-1776      

Counts SE;Perez SE;Ginsberg SD;De Lacalle S;Mufson EJ;    Galanin in Alzheimer disease.  Molecular Interventions.  2003;3(3):137-156      

Cox CL;Gotimer K;Roy AK;Castellanos FX;Milham MP;Kelly C;    (non-copyrighted -attachment )
Your resting brain CAREs about your risky behavior.  PLoS ONE.  2010;5(8):      

Cunha C;Monfils MH;Ledoux JE;    GABA(C) receptors in the lateral amygdala: a possible novel target for the treatment of fear and anxiety disorders?.  Frontiers in Behavioral Neuroscience.  2010;4:6      

Czobor P;Volavka J;    Positive and negative symptoms: is their change related?.  Schizophrenia Bulletin.  1996;22(4):577-590      

D'Souza DC;Perry E;MacDougall L;Ammerman Y;Cooper T;Wu YT;Braley G;Gueorguieva R;Krystal JH;    The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.  Neuropsychopharmacology.  2004;29(8):1558-1572      

das Neves MC;Tremeau F;Nicolato R;Lauar H;Romano-Silva MA;Correa H;    Facial emotion recognition deficits in relatives of children with autism are not associated with 5HTTLPR.  Revista Brasileira de Psiquiatria.  2011;33(3):261-267      

de Leon MJ;Convit A;Wolf OT;Tarshish CY;DeSanti S;Rusinek H;Tsui W;Kandil E;Scherer AJ;Roche A;Imossi A;Thorn E;Bobinski M;Caraos C;Lesbre P;Schlyer D;Poirier J;Reisberg B;Fowler J;    Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).  Proceedings of the National Academy of Sciences of the United States of America.  2001;98(19):10966-10971      

de Leon MJ;McRae T;Rusinek H;Convit A;De Santi S;Tarshish C;Golomb J;Volkow N;Daisley K;Orentreich N;McEwen B;    Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.  Journal of Clinical Endocrinology & Metabolism.  1997;82(10):3251-3259      

De Sanctis P;Molholm S;Shpaner M;Ritter W;Foxe JJ;    Right hemispheric contributions to fine auditory temporal discriminations: High-density electrical mapping of the duration mismatch negativity (MMN).  Frontiers in Integrative Neuroscience.  2009;3:5      

De Sanctis P;Ritter W;Molholm S;Kelly SP;Foxe JJ;    Auditory scene analysis: the interaction of stimulation rate and frequency separation on pre-attentive grouping.  European Journal of Neuroscience.  2008;27(5):1271-1276      

Delay C;Calon F;Mathews P;Hebert SS;    Alzheimer-specific variants in the 3'UTR of amyloid precursor protein affect microRNA function.  Molecular Neurodegeneration.  2011;6:70      

Delgado MR;Jou RL;Ledoux JE;Phelps EA;    Avoiding negative outcomes: tracking the mechanisms of avoidance learning in humans during fear conditioning.  Frontiers in Behavioral Neuroscience.  2009;3:33      

DeLisi LE;    Searching for the true genetic vulnerability for schizophrenia.  Genome Medicine.  2009;1:14      

DeLisi LE;    The Katrina disaster and its lessons.  World Psychiatry.  2006;5(1):3-4      

DeLisi LE;    The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia.  Schizophrenia Bulletin.  2008;34(2):312-321      

DeLisi LE;    Dr. DeLisi replies.  American Journal of Psychiatry.  2004;161(8):1508-1509      

DeLisi LE;Bertisch HC;Brown K;Majcher M;Bappal A;Szulc KU;Ardekani BA;    A preliminary DTI study showing no brain structural change associated with adolescent cannabis use.  Harm Reduction Journal.  2006;3(1):17      

DeLisi LE;Crow TJ;    Drs. DeLisi and Crow reply.  American Journal of Psychiatry.  2003;160(3):598-599      

DeLisi LE;Maurizio A;Yost M;Papparozzi CF;Fulchino C;Katz CL;Altesman J;Biel M;Lee J;Stevens P;    A survey of New Yorkers after the Sept. 11, 2001, terrorist attacks.  American Journal of Psychiatry.  2003;160(4):780-783      

DeLisi LE;Shaw SH;Crow TJ;Shields G;Smith AB;Larach VW;Wellman N;Loftus J;Nanthakumar B;Razi K;Stewart J;Comazzi M;Vita A;Heffner T;Sherrington R;    A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder.  American Journal of Psychiatry.  2002;159(5):803-812      

DeLisi LE;Szulc KU;Bertisch H;Majcher M;Brown K;Bappal A;Branch CA;Ardekani BA;    Early detection of schizophrenia by diffusion weighted imaging.  Psychiatry Research: Neuroimaging.  2006;148(1):61-66      

Devanand DP;Marder K;Michaels KS;Sackeim HA;Bell K;Sullivan MA;Cooper TB;Pelton GH;Mayeux R;    A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.  American Journal of Psychiatry.  1998;155(11):1512-1520      

Devi L;Alldred MJ;Ginsberg SD;Ohno M;    (non-copyrighted -attachment )
Sex- and brain region-specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease.  Molecular Brain.  2010;3:34      

Devi L;Ohno M;    (non-copyrighted -attachment )
Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice.  PLoS ONE.  2010;5(9):e12974      

Di Russo F;Martinez A;Hillyard SA;    Source analysis of event-related cortical activity during visuo-spatial attention.  Cerebral Cortex.  2003;13(5):486-499      

Dias EC;Foxe JJ;Javitt DC;    Changing plans: a high density electrical mapping study of cortical control.  Cerebral Cortex.  2003;13(7):701-715      

Dias EC;Segraves MA;    Muscimol-induced inactivation of monkey frontal eye field: effects on visually and memory-guided saccades.  Journal of Neurophysiology.  1999;81(5):2191-2214      

Dixon LB;Lehman AF;Levine J;    Conventional antipsychotic medications for schizophrenia. [Review].  Schizophrenia Bulletin.  1995;21(4):567-577      

Dockstader C;Gaetz W;Cheyne D;Wang F;Castellanos FX;Tannock R;    MEG event-related desynchronization and synchronization deficits during basic somatosensory processing in individuals with ADHD.  Behavioral and Brain Functions.  2008;4:8      

Doniger GM;Foxe JJ;Murray MM;Higgins BA;Javitt DC;    Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia.  Archives of General Psychiatry.  2002;59(11):1011-1020      

Doniger GM;Silipo G;Rabinowicz EF;Snodgrass JG;Javitt DC;    Impaired sensory processing as a basis for object-recognition deficits in schizophrenia.  American Journal of Psychiatry.  2001;158(11):1818-1826      

Duff K;Suleman F;    Transgenic mouse models of Alzheimer's disease: How useful have they been for therapeutic development?.  Briefings in Functional Genomics and Proteomics.  2004;3(1):47-59      

Duffy AM;Schaner MJ;Wu SH;Staniszewski A;Kumar A;Arevalo JC;Arancio O;Chao MV;Scharfman HE;    A selective role for ARMS/Kidins220 scaffold protein in spatial memory and trophic support of entorhinal and frontal cortical neurons.  Experimental Neurology.  2011;229(2):409-420      

Dussias P;Kalali AH;Citrome L;    (non-copyrighted -attachment )
Polypharmacy of schizophrenia.  Psychiatry MMC.  2010;7(8):17-19      

Ehrlich ME;Sommer J;Canas E;Unterwald EM;    Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine.  Journal of Neuroscience.  2002;22(21):9155-9159      

Farb CR;Chang W;Ledoux JE;    (non-copyrighted -attachment )
Ultrastructural characterization of noradrenergic axons and beta-adrenergic receptors in the lateral nucleus of the amygdala.  Frontiers in Behavioral Neuroscience.  2010;4:162      

Feng J;Chi P;Blanpied TA;Xu Y;Magarinos AM;Ferreira A;Takahashi RH;Kao HT;McEwen BS;Ryan TA;Augustine GJ;Greengard P;    Regulation of neurotransmitter release by synapsin III.  Journal of Neuroscience.  2002;22(11):4372-4380      

Ferris SH;Schmitt FA;Saxton J;Richardson S;Mackell J;Sun Y;Xu Y;    Analyzing the impact of donepezil 23 mg/d on language dysfunction in moderate to severe Alzheimer's disease.  Alzheimer's Research & Therapy.  2011;3(3):22      

FitzGerald M;Malone KM;Li S;Harrison WM;McBride PA;Endicott J;Cooper T;Mann JJ;    Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.  American Journal of Psychiatry.  1997;154(4):556-558      

Foxe JJ;Murray MM;Javitt DC;    Filling-in in schizophrenia: a high-density electrical mapping and source-analysis investigation of illusory contour processing.  Cerebral Cortex.  2005;15(12):1914-1927      

Foxe JJ;Wylie GR;Martinez A;Schroeder CE;Javitt DC;Guilfoyle D;Ritter W;Murray MM;    Auditory-somatosensory multisensory processing in auditory association cortex: an fMRI study.  Journal of Neurophysiology.  2002;88(1):540-543      

Francks C;DeLisi LE;Fisher SE;Laval SH;Rue JE;Stein JF;Monaco AP;    Confirmatory evidence for linkage of relative hand skill to 2p12-q11.  American Journal of Human Genetics.  2003;72(2):499-502      

Francks C;DeLisi LE;Shaw SH;Fisher SE;Richardson AJ;Stein JF;Monaco AP;    Parent-of-origin effects on handedness and schizophrenia susceptibility on chromosome 2p12-q11.  Human Molecular Genetics.  2003;12(24):3225-3230      

Frangos J;Ritter W;Friedman D;    Brain potentials to sexually suggestive whistles show meaning modulates the mismatch negativity.  Neuroreport.  2005;16(12):1313-1317      

Frederikse PH;Yun E;Kao HT;Zigler JS;Sun Q;Qazi AS;    Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation.  Molecular Vision.  2004;10:794-804      

Fu KM;Johnston TA;Shah AS;Arnold L;Smiley J;Hackett TA;Garraghty PE;Schroeder CE;    Auditory cortical neurons respond to somatosensory stimulation.  Journal of Neuroscience.  2003;23(20):7510-7515      

Fu KM;Shah AS;O' Connell MN;McGinnis T;Eckholdt H;Lakatos P;Smiley J;Schroeder CE;    Timing and laminar profile of eye position effects on auditory responses in primate auditory cortex.  Journal of Neurophysiology.  2004;92(6):3522-3531      

Gabbay V;Hess DA;Liu S;Babb JS;Klein RG;Gonen O;    Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study.  American Journal of Psychiatry.  2007;164(12):1881-1889      

Gabbay V;Liebes L;Katz Y;Liu S;Mendoza S;Babb JS;Klein RG;Gonen O;    (non-copyrighted -attachment )
The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.  Progress in Neuro-Psychopharmacology & Biological Psychiatry.  2010;34(1):37-44      

Galanter M;    My Name Is Bill: Bill Wilson--His Life and the Creation of Alcoholics Anonymous [Book Review].  American Journal of Psychiatry.  2005;162(5):1037-1038      

Galanter M;    Innovations: alcohol & drug abuse: spirituality in Alcoholics Anonymous: a valuable adjunct to psychiatric services.  Psychiatric Services.  2006;57(3):307-309      

Galanter M;    Healing through social and spiritual affiliation.  Psychiatric Services.  2002;53(9):1072-1074      

Galanter M;    Self-help treatment for combined addiction and mental illness.  Psychiatric Services.  2000;51(8):977-979      

Galanter M;Dermatis H;Egelko S;De Leon G;    Homelessness and mental illness in a professional- and peer-led cocaine treatment clinic.  Psychiatric Services.  1998;49(4):533-535      

Galanter M;Glickman L;Dermatis H;Tracy K;McMahon C;    Addressing patients' spirituality in medical treatment.  Primary Psychiatry.  2008;15(9):82-90      

Galanter M;Keller DS;Dermatis H;    Using the Internet for clinical training: a course on network therapy for substance abuse.  Psychiatric Services.  1997;48(8):999-1000      

Gandy S;Almeida OP;Fonte J;Lim D;Waterrus A;Spry N;Flicker L;Martins RN;    Chemical andropause and amyloid-beta peptide.  JAMA.  2001;285(17):2195-2196      

Gandy S;Petanceska S;    Authors' reply.  PLoS Medicine.  2005;2(3):e85      

Gao XM;Cooper T;Suckow RF;Tamminga CA;    Multidose risperidone treatment evaluated in a rodent model of tardive dyskinesia.  Neuropsychopharmacology.  2006;31(9):1864-1868      

Garcia-Quispe LA;Gordon J;Zemon V;    Development of contrast mechanisms in humans: a VEP study.  Optometry & Vision Science.  2009;86(6):708-716      

Gaspar PA;Ruiz S;Zamorano F;Altayo M;Perez C;Bosman CA;Aboitiz F;    P300 amplitude is insensitive to working memory load in schizophrenia.  BMC Psychiatry.  2011;11:29      

George AE;de Leon MJ;Golomb J;Kluger A;Convit A;    Imaging the brain in dementia: expensive and futile?.  American Journal of Neuroradiology.  1997;18(10):1847-1850      

Ghidoni R;Paterlini A;Albertini V;Glionna M;Monti E;Schiaffonati L;Benussi L;Levy E;Binetti G;    Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer's disease.  Neurobiology of Aging.  2011;32(8):1435-1442      

Ghoshal N;Smiley JF;DeMaggio AJ;Hoekstra MF;Cochran EJ;Binder LI;Kuret J;    A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease.  American Journal of Pathology.  1999;155(4):1163-1172      

Ginsberg SD;    Transcriptional profiling of small samples in the central nervous system.  Methods in Molecular Biology.  2008;439:147-158      

Ginsberg SD;Che S;    Combined histochemical staining, RNA amplification, regional, and single cell cDNA analysis within the hippocampus.  Laboratory Investigation.  2004;84(8):952-962      

Ginsberg SD;Mufson EJ;Counts SE;Wuu J;Alldred MJ;Nixon RA;Che S;    Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease.  Journal of Alzheimer's Disease.  2010;22(2):631-639      

Gitler D;Xu Y;Kao HT;Lin D;Lim S;Feng J;Greengard P;Augustine GJ;    Molecular determinants of synapsin targeting to presynaptic terminals.  Journal of Neuroscience.  2004;24(14):3711-3720      

Glazer WM;Conley RR;Citrome L;    Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study.  CNS Spectrums.  2006;11(9 (Suppl 10)):1-13      

Glodzik L;De SS;Tsui WH;Mosconi L;Zinkowski R;Pirraglia E;Wang HY;Li Y;Rich KE;Zetterberg H;Blennow K;Mehta P;de Leon MJ;    Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.  Neurobiology of Aging.  2011;32(12):2131-2141      

Gong B;Vitolo OV;Trinchese F;Liu S;Shelanski M;Arancio O;    Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.  Journal of Clinical Investigation.  2004;114(11):1624-1634      

Goodman AB;    Three independent lines of evidence suggest retinoids as causal to schizophrenia.  Proceedings of the National Academy of Sciences of the United States of America.  1998;95(13):7240-7244      

Grbovic OM;Mathews PM;Jiang Y;Schmidt SD;Dinakar R;Summers-Terio NB;Ceresa BP;Nixon RA;Cataldo AM;    Rab5-stimulated up-regulation of the endocytic pathway increases intracellular {beta}-cleaved amyloid precursor protein carboxyl-terminal fragment levels and A{beta} production.  Journal of Biological Chemistry.  2003;278(33):31261-31268      

Green MF;Butler PD;Chen Y;Geyer MA;Silverstein S;Wynn JK;Yoon JH;Zemon V;    Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.  Schizophrenia Bulletin.  2009;35(1):163-181      

Greenberg WM;    Book review: The Antidepressant Survival Program: How to Beat the Side Effects and Enhance the Benefits of Your Medication, by Robert Hedaya.  American Journal of Psychiatry.  2002;159(1):167      

Greenberg WM;    Book review: Guidelines for the Systematic Treatment of the Depressed Patient, by Larry Beutler, John Clarkin and Bruce Bongar.  American Journal of Psychiatry.  2002;159(7):1256      

Greenberg WM;    Book review: Descriptions and Prescriptions: Values, Mental Disorders and the DSMs, edited by John Z. Sadler [correction in Am J Psychiatry 160:1537, August 2003].  American Journal of Psychiatry.  2003;160(5):1021-1022      

Greenberg WM;    Book review: Atypical Antipsychotics: From Bench to Bedside.  American Journal of Psychiatry.  2005;162(3):642-643      

Greenberg WM;    The Biopsychosocial Approach: Past, Present, Future [book review].  American Journal of Psychiatry.  2005;162(7):1398      

Greenfield JP;Xu HX;Greengard P;Gandy S;Seeger M;    Generation of the amyloid-beta peptide N terminus in Saccharomyces cerevisiae expressing human Alzheimer's amyloid-beta precursor protein.  Journal of Biological Chemistry.  1999;274(48):33843-33846      

Grover A;Houlden H;Baker M;Adamson J;Lewis J;Prihar G;Pickering-Brown S;Duff K;Hutton M;    5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.  Journal of Biological Chemistry.  1999;274(21):15134-15143      

Grundman M;Petersen RC;Ferris SH;Thomas RG;Aisen PS;Bennett DA;Foster NL;Jack CR;Galasko DR;Doody R;Kaye J;Sano M;Mohs R;Gauthier S;Kim HT;Jin S;Schultz AN;Schafer K;Mulnard R;van Dyck CH;Mintzer J;Zamrini EY;Cahn-Weiner D;Thal LJ;    Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.  Archives of Neurology.  2004;61(1):59-66      

Guerra CB;Busch R;Doebele RC;Liu W;Sawada T;Kwok WW;Chang MD;Mellins ED;    Novel glycosylation of HLA-DRalpha disrupts antigen presentation without altering endosomal localization.  Journal of Immunology.  1998;160(9):4289-4297      

Gugino LD;Chabot RJ;Prichep LS;John ER;Formanek V;Aglio LS;    Quantitative EEG changes associated with loss and return of consciousness in healthy adult volunteers anaesthetized with propofol or sevoflurane.  British Journal of Anaesthesia.  2001;87(3):421-428      

Guo N;Hwang DR;Lo ES;Huang YY;Laruelle M;Abi-Dargham A;    Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.  Neuropsychopharmacology.  2003;28(9):1703-1711      

Gyulai L;Bowden CL;McElroy SL;Calabrese JR;Petty F;Swann AC;Chou JC;Wassef A;Risch CS;Hirschfeld RM;Nemeroff CB;Keck PE;Evans DL;Wozniak PJ;    Maintenance efficacy of divalproex in the prevention of bipolar depression.  Neuropsychopharmacology.  2003;28(7):1374-1382      

Hagler DJ;Halgren E;Martinez A;Huang M;Hillyard SA;Dale AM;    Source estimates for MEG/EEG visual evoked responses constrained by multiple, retinotopically-mapped stimulus locations.  Human Brain Mapping.  2009;30(4):1290-1309      

Harrison G;Hopper K;Craig T;Laska E;Siegel C;Wanderling J;Dube KC;Ganev K;Giel R;an der HW;Holmberg SK;Janca A;Lee PW;Leon CA;Malhotra S;Marsella AJ;Nakane Y;Sartorius N;Shen Y;Skoda C;Thara R;Tsirkin SJ;Varma VK;Walsh D;Wiersma D;    Recovery from psychotic illness: a 15- and 25-year international follow-up study.  British Journal of Psychiatry.  2001;178:506-517      

Hasegawa H;Sanjo N;Chen F;Gu YJ;Shier C;Petit A;Kawarai T;Katayama T;Schmidt S;Mathews P;Ulms G;Fraser PE;St George-Hyslop P;    Both the sequence and length of the C-terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes.  Journal of Biological Chemistry.  2004;279(45):46455-46463      

Haskew-Layton RE;Payappilly JB;Smirnova NA;Ma TC;Chan KK;Murphy TH;Guo H;Langley B;Sultana R;Butterfield DA;Santagata S;Alldred MJ;Gazaryan IG;Bell GW;Ginsberg SD;Ratan RR;    (non-copyrighted -attachment )
Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway.  Proceedings of the National Academy of Sciences of the United States of America.  2010;107(40):17385-17390      

Haugland G;Siegel C;Hopper K;Alexander MJ;    Mental illness among homeless individuals in a suburban county.  Psychiatric Services.  1997;48(4):504-509      

Heijtz RD;Alexeyenko A;Castellanos FX;    Calcyon mRNA expression in the frontal-striatal circuitry and its relationship to vesicular processes and ADHD.  Behavioral and Brain Functions.  2007;3(1):33      

Helpern JA;    The missing element [editorial].  American Journal of Neuroradiology.  2001;22(7):1235-1236      

Helpern JA;    The promise of high-field-strength MR imaging.  American Journal of Neuroradiology.  2003;24(9):1738-1739      

Hemby SE;Ginsberg SD;Brunk B;Arnold SE;Trojanowski JQ;Eberwine JH;    Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex.  Archives of General Psychiatry.  2002;59(7):631-640      

Heresco-Levy U;Ermilov M;Shimoni J;Shapira B;Silipo G;Javitt DC;    Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.  American Journal of Psychiatry.  2002;159(3):480-482      

Heresco-Levy U;Javitt DC;Ermilov M;Mordel C;Silipo G;Lichtenstein M;    Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.  Archives of General Psychiatry.  1999;56(1):29-36      

Hirasawa M;Ohshima T;Takahashi S;Longenecker G;Honjo Y;Veeranna;Pant HC;Mikoshiba K;Brady RO;Kulkarni AB;    Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects.  Proceedings of the National Academy of Sciences of the United States of America.  2004;101(16):6249-6254      

Hopper K;    Rethinking social recovery in schizophrenia: what a capabilities approach might offer.  Social Science & Medicine.  2007;65(5):868-879      

Hopper K;    Returning to the community--again [editorial].  Psychiatric Services.  2002;53(11):1355      

Hopper K;    Qualitative and quantitative research: two cultures.  Psychiatric Services.  2008;59(7):711      

Hopper K;Barrow SM;    Two genealogies of supported housing and their implications for outcome assessment.  Psychiatric Services.  2003;54(1):50-54      

Hopper K;Jost J;Hay T;Welber S;Haugland G;    Homelessness, severe mental illness, and the institutional circuit.  Psychiatric Services.  1997;48(5):659-665      

Hopper K;Wanderling J;    Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: Results from ISoS, the WHO collaborative followup project.  Schizophrenia Bulletin.  2000;26(4):835-846      

Hoptman MJ;Ardekani BA;Butler PD;Nierenberg J;Javitt DC;Lim KO;    DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis.  Neuroreport.  2004;15(16):2467-2470      

Hoptman MJ;Gunning-Dixon FM;Murphy CF;Lim KO;Alexopoulos GS;    Structural neuroimaging research methods in geriatric depression [erratum appears in Am J Geriatr Psychiatry. 2006 Nov;14(11):988]..  American Journal of Geriatric Psychiatry.  2006;14(10):812-822      

Hoptman MJ;Volavka J;Czobor P;Gerig G;Chakos M;Blocher J;Citrome LL;Sheitman B;Lindenmayer JP;Lieberman JA;Bilder RM;    Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder.  Journal of Neuropsychiatry & Clinical Neurosciences.  2006;18(4):509-515      

Hoptman MJ;Volavka J;Weiss EM;Czobor P;Szeszko PR;Gerig G;Chakos M;Blocher J;Citrome LL;Lindenmayer JP;Sheitman B;Lieberman JA;Bilder RM;    Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.  Psychiatry Research.  2005;140(2):133-145      

Hoptman MJ;Yates KF;Patalinjug MB;Wack RC;Convit A;    Clinical prediction of assaultive behavior among male psychiatric patients at a maximum-security forensic facility.  Psychiatric Services.  1999;50(11):1461-1466      

Hrabe J;Hrabetova S;Segeth K;    A model of effective diffusion and tortuosity in the extracellular space of the brain.  Biophysical Journal.  2004;87(3):1606-1617      

Hrabe J;Kaur G;Guilfoyle DN;    Principles and limitations of NMR diffusion measurements.  Journal of Medical Physics.  2007;32(1):34-42      

Hrabetova S;Hrabe J;Nicholson C;    Dead-space microdomains hinder extracellular diffusion in rat neocortex during ischemia.  Journal of Neuroscience.  2003;23(23):8351-8359      

Hughes JR;John ER;    Conventional and quantitative electroencephalography in psychiatry.  Journal of Neuropsychiatry & Clinical Neurosciences.  1999;11(2):190-208      

Hui KS;Saito M;Hui M;    A novel neuron-specific aminopeptidase in rat brain synaptosomes: its identification, purification, and characterization.  Journal of Biological Chemistry.  1998;273(47):31053-31060      

Hungund BL;    Editorial: Role of endocannabinoid signaling in alcohol and drug addiction (Guest Editor: Basalingappa L. Hungund).  The Open Neuropsychopharmacology Journal.  2009;2:30      

Hungund BL;Basavarajappa BS;    Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence.  Alcohol and Alcoholism.  2000;35(2):126-133      

Hungund BL;Vinod KY;    Role of the endocannabinoid system in alcohol-related behaviors.  The Open Neuropsychopharmacology Journal.  2009;2:31-39      

Imperati D;Colcombe S;Kelly C;Di MA;Zhou J;Castellanos FX;Milham MP;    Differential development of human brain white matter tracts.  PLoS ONE.  2011;6(8):e23437      

Ivkovic S;Ehrlich ME;    Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro.  Journal of Neuroscience.  1999;19(13):5409-5419      

Jaffe AB;    Neuropsychiatry: An Introductory Approach (book review).  Journal of Neuropsychiatry & Clinical Neurosciences.  2003;15(2):239-240      

Javitt DC;    Glutamate involvement in schizophrenia: focus on N-methyl-D-aspartate receptors.  Primary Psychiatry.  2006;13(10):38-46      

Javitt DC;    (non-copyrighted -attachment )
Glutamatergic theories of schizophrenia.  Israel Journal of Psychiatry & Related Sciences.  2010;47(1):4-16      

Javitt DC;Balla A;Burch S;Suckow R;Xie S;Sershen H;    Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists.  Neuropsychopharmacology.  2004;29(2):300-307      

Javitt DC;Hashim A;Sershen H;    Modulation of striatal dopamine release by glycine transport inhibitors.  Neuropsychopharmacology.  2005;30(4):649-656      

Javitt DC;Liederman E;Cienfuegos A;Shelley A;    Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia.  Schizophrenia Bulletin.  1999;25(4):763-775      

Javitt DC;Rabinowicz E;Silipo G;Dias EC;    Encoding vs. retention: differential effects of cue manipulation on working memory performance in schizophrenia.  Schizophrenia Research.  2007;91(1-3):159-168      

Javitt DC;Sershen H;Hashim A;Lajtha A;    Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide.  Neuropsychopharmacology.  1997;17(3):202-204      

Javitt DC;Shelley AM;Silipo G;Lieberman JA;    Deficits in auditory and visual context-dependent processing in schizophrenia - Defining the pattern.  Archives of General Psychiatry.  2000;57(12):1131-1137      

Javitt DC;Steinschneider M;Schroeder CE;Arezzo JC;    Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.  Proceedings of the National Academy of Sciences of the United States of America.  1996;93(21):11962-11967      

Jensen JH;Szulc K;Hu C;Ramani A;Lu H;Xuan L;Falangola MF;Chandra R;Knopp EA;Schenck J;Zimmerman EA;Helpern JA;    Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain.  Magnetic Resonance in Medicine.  2009;61(2):481-485      

Johnson KA;Robertson IH;Kelly SP;Silk TJ;Barry E;Daibhis A;Watchorn A;Keavey M;FitzGerald M;Gallagher L;Gill M;Bellgrove MA;    Dissociation in performance of children with ADHD and high-functioning autism on a task of sustained attention.  Neuropsychologia.  2007;45(10):2234-2245      

Johnson LR;Hou M;Ponce-Alvarez A;Gribelyuk LM;Alphs HH;Albert L;Brown BL;Ledoux JE;Doyere V;    A recurrent network in the lateral amygdala: a mechanism for coincidence detection.  Frontiers in Neural Circuits.  2008;2:3      

Johnson LR;Hou M;Prager EM;Ledoux JE;    Regulation of the fear network by mediators of stress: norepinephrine alters the balance between cortical and subcortical afferent excitation of the lateral amygdala.  Frontiers in Behavioral Neuroscience.  2011;5:23      

Johnson LR;Ledoux JE;Doyere V;    Hebbian reverberations in emotional memory micro circuits.  Frontiers in Neuroscience.  2009;3(2):198-205      

Jones K;Colson PW;Holter MC;Lin S;Valencia E;Susser E;Wyatt RJ;    Cost-effectiveness of critical time intervention to reduce homelessness among persons with mental illness.  Psychiatric Services.  2003;54(6):884-890      

Kane JM;Eerdekens M;Lindenmayer JP;Keith SJ;Lesem M;Karcher K;    Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.  American Journal of Psychiatry.  2003;160(6):1125-1132      

Kantrowitz J;Citrome L;    Paliperidone: the evidence of its therapeutic value in schizophrenia.  Core Evidence.  2008;2(4):261-271      

Kantrowitz JT;Javitt DC;    Glutamate: new hope for schizophrenia treatment.  Current Psychiatry.  2011;10(4):69-74      

Katz CL;Gluck N;Maurizio A;DeLisi LE;    The medical student experience with disasters and disaster response.  CNS Spectrums.  2002;7(8):604-610      

Kaur G;Hrabetova S;Guilfoyle DN;Nicholson C;Hrabe J;    Characterizing molecular probes for diffusion measurements in the brain.  Journal of Neuroscience Methods.  2008;171(2):218-225      

Kelly RE;Wang Z;Alexopoulos GS;Gunning FM;Murphy CF;Morimoto SS;Kanellopoulos D;Jia Z;Lim KO;Hoptman MJ;    (non-copyrighted -attachment )
Hybrid ICA-seed-based methods for fMRI functional connectivity assessment: a feasibility study.  International Journal of Biomedical Imaging.  2010;2010:      

Kelly SP;Lalor EC;Reilly RB;Foxe JJ;    Increases in alpha oscillatory power reflect an active retinotopic mechanism for distracter suppression during sustained visuo-spatial attention.  Journal of Neurophysiology.  2006;95(6):3844-3851      

Kessler RC;Berglund PA;Bruce ML;Koch JR;Laska EM;Leaf PJ;Manderscheid RW;Rosenheck RA;Walters EE;Wang PS;    The prevalence and correlates of untreated serious mental illness.  Health Services Research.  2001;36(6 Pt 1):987-1007      

Khachaturian ZS;Petersen RC;Gauthier S;Buckholtz N;Corey-Bloom JP;Evans B;Fillit H;Foster N;Greenberg B;Grundman M;Sano M;Simpkins J;Schneider LS;Weiner MW;Galasko D;Hyman B;Kuller L;Schenk D;Snyder S;Thomas RG;Tuszynski MH;Vellas B;Wurtman RJ;Snyder PJ;Frank RA;Albert M;Doody R;Ferris S;Kaye J;Koo E;Morrison-Bogorad M;Reisberg B;Salmon DP;Gilman S;Mohs R;Aisen PS;Breitner JC;Cummings JL;Kawas C;Phelps C;Poirier J;Sabbagh M;Touchon J;Khachaturian AS;Bain LJ;    A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.  Alzheimer's and Dementia.  2008;4(3):156-163      

Khan A;Lewis C;Lindenmayer JP;    Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).  BMC Psychiatry.  2011;11:178      

Kim D;Wylie G;Pasternak R;Butler PD;Javitt DC;    Magnocellular contributions to impaired motion processing in schizophrenia.  Schizophrenia Research.  2006;82(1):1-8      

King SR;Ginsberg SD;Ishii T;Smith RG;Parker KL;Lamb DJ;    The steroidogenic acute regulatory (StAR) protein Is expressed in steroidogenic cells of the day-old (P1) brain.  Endocrinology.  2004;145(10):4775-4780      

King SR;Manna PR;Ishii T;Syapin PJ;Ginsberg SD;Wilson K;Walsh LP;Parker KL;Stocco DM;Smith RG;Lamb DJ;    An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain.  Journal of Neuroscience.  2002;22(24):10613-10620      

Klein RL;Lin WL;Dickson DW;Lewis J;Hutton M;Duff K;Meyer EM;King MA;    Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau.  American Journal of Pathology.  2004;164(1):347-353      

Knuth KH;Shah AS;Truccolo WA;Ding M;Bressler SL;Schroeder CE;    Differentially variable component analysis: identifying multiple evoked components using trial-to-trial variability.  Journal of Neurophysiology.  2006;95(5):3257-3276      

Komano H;Seeger M;Gandy S;Wang GT;Krafft GA;Fuller RS;    Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast.  Journal of Biological Chemistry.  1998;273(48):31648-31651      

Kowa H;Sakakura T;Matsuura Y;Wakabayashi T;Mann DM;Duff K;Tsuji S;Hashimoto T;Iwatsubo T;    Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.  American Journal of Pathology.  2004;165(1):273-281      

Krakowski M;    Violent behavior: choosing antipsychotics and other agents.  Current Psychiatry.  2007;6(4):63-70      

Krakowski M;    Violence and serotonin: influence of impulse control, affect regulation, and social functioning.  Journal of Neuropsychiatry & Clinical Neurosciences.  2003;15(3):294-305      

Krakowski M;Czobor P;    Gender differences in violent behaviors: relationship to clinical symptoms and psychosocial factors.  American Journal of Psychiatry.  2004;161(3):459-465      

Krakowski M;Czobor P;Carpenter MD;Libiger J;Kunz M;Papezova H;Parker BB;Schmader L;Abad T;    Community violence and inpatient assaults: neurobiological deficits.  Journal of Neuropsychiatry & Clinical Neurosciences.  1997;9(4):549-555      

Krakowski M;Czobor P;Chou JCY;    Course of violence in patients with schizophrenia: Relationship to clinical symptoms.  Schizophrenia Bulletin.  1999;25(3):505-517      

Krakowski MI;Czobor P;    Psychosocial risk factors associated with suicide attempts and violence among psychiatric inpatients.  Psychiatric Services.  2004;55(12):1414-1419      

Krakowski MI;Czobor P;Citrome L;Bark N;Cooper TB;    Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.  Archives of General Psychiatry.  2006;63(6):622-629      

Kritz S;Brown LS;Goldsmith RJ;Bini EJ;Robinson J;Alderson D;Novo P;Rotrosen J;    States and substance abuse treatment programs: funding and guidelines for infection-related services.  American Journal of Public Health.  2008;98(5):824-826      

Krystal JH;Perry EB;Gueorguieva R;Belger A;Madonick SH;bi-Dargham A;Cooper TB;MacDougall L;Abi-Saab W;D'Souza DC;    Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.  Archives of General Psychiatry.  2005;62(9):985-994      

Kumar-Singh S;Pirici D;McGowan E;Serneels S;Ceuterick C;Hardy J;Duff K;Dickson D;Van BC;    Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.  American Journal of Pathology.  2005;167(2):527-543      

Kunz M;Yates KF;Czobor P;Rabinowitz S;Lindenmayer JP;Volavka J;    Course of patients with histories of aggression and crime after discharge from a cognitive-behavioral program.  Psychiatric Services.  2004;55(6):654-659      

Kurylo DD;Pasternak R;Silipo G;Javitt DC;Butler PD;    Perceptual organization by proximity and similarity in schizophrenia.  Schizophrenia Research.  2007;95(1-3):205-214      

Lachman HM;Nolan KA;Mohr P;Saito T;Volavka J;    Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder.  American Journal of Psychiatry.  1998;155(6):835-837      

Lacombe P;Mathews PM;Schmidt SD;Breidert T;Heneka MT;Landreth GE;Feinstein DL;Galea E;    Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised.  Journal of Neuroinflammation.  2004;1:11      

Lakatos P;Karmos G;Mehta AD;Ulbert I;Schroeder CE;   
Entrainment of neuronal oscillations as a mechanism of attentional selection.  Science.  2008;320(5872):110-113      

Lakatos P;Shah AS;Knuth KH;Ulbert I;Karmos G;Schroeder CE;    An oscillatory hierarchy controlling neuronal excitability and stimulus processing in the auditory cortex.  Journal of Neurophysiology.  2005;94(3):1904-1911      

Lalor EC;Kelly SP;Pearlmutter BA;Reilly RB;Foxe JJ;    Isolating endogenous visuo-spatial attentional effects using the novel visual-evoked spread spectrum analysis (VESPA) technique.  European Journal of Neuroscience.  2007;26(12):3536-3542      

Laska EM;    The use of capture-recapture methods in public health [editorial].  Bulletin of the World Health Organization.  2002;80(11):845      

Laudon H;Karlstrom H;Mathews PM;Farmery MR;Gandy SE;Lundkvist J;Lendahl U;Naslund J;    Functional domains in presenilin 1: the Tyr-288 residue controls gamma -secretase activity and endoproteolysis.  Journal of Biological Chemistry.  2004;279(23):23925-23932      

Leadbetter RA;Shutty MS;Elkashef AM;Kirch DG;Spraggins T;Cail WS;Wu H;Bilder RM;Lieberman JA;Wyatt RJ;    MRI changes during water loading in patients with polydipsia and intermittent hyponatremia.  American Journal of Psychiatry.  1999;156(6):958-960      

Leavitt VM;Molholm S;Gomez-Ramirez M;Foxe JJ;    'What' and 'where' in auditory sensory processing: a high-density electrical mapping study of distinct neural processes underlying sound object recognition and sound localization.  Frontiers in Integrative Neuroscience.  2011;5:23      

Leavitt VM;Molholm S;Ritter W;Shpaner M;Foxe JJ;    Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits [correction in vol. 32(6): 438].  Journal of Psychiatry & Neuroscience.  2007;32(5):339-353      

Lebedev S;Van Gelder P;Tsui WH;    Square-root relations between main saccadic parameters.  Investigative Ophthalmology & Visual Science.  1996;37(13):2750-2758      

Lebon V;Petersen KF;Cline GW;Shen J;Mason GF;Dufour S;Behar KL;Shulman GI;Rothman DL;    Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism.  Journal of Neuroscience.  2002;22(5):1523-1531      

Ledoux J;    Music and the brain, literally.  Frontiers in Human Neuroscience.  2011;5:49      

Leitman DI;Hoptman MJ;Foxe JJ;Saccente E;Wylie GR;Nierenberg J;Jalbrzikowski M;Lim KO;Javitt DC;    The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents.  American Journal of Psychiatry.  2007;164(3):474-482      

Leitman DI;Sehatpour P;Garidis C;Gomez-Ramirez M;Javitt DC;    Preliminary evidence of pre-attentive distinctions of frequency-modulated tones that convey affect.  Frontiers in Human Neuroscience.  2011;5:96      

Leitman DI;Wolf DH;Ragland JD;Laukka P;Loughead J;Valdez JN;Javitt DC;Turetsky BI;Gur RC;    (non-copyrighted -attachment )
'It's not what you say, but how you say it': a reciprocal temporo-frontal network for affective prosody.  Frontiers in Human Neuroscience.  2010;4:19      

Lencz T;Bilder RM;Turkel E;Goldman RS;Robinson D;Kane JM;Lieberman JA;    Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia.  Archives of General Psychiatry.  2003;60(3):238-243      

Lencz T;Cornblatt B;Bilder RM;    Neurodevelopmental models of schizophrenia: pathophysiologic synthesis and directions for intervention research.  Psychopharmacology Bulletin.  2001;35(1):95-125      

Levine IS;Moss S;    Mental health resources on the web for families: a quick reference guide.  .  2002;revised 4/02:      

Levine J;Jaffe A;    Antipsychotic medication utilization in a state mental hospital system, 1994-2000.  .  2004;:199-208      

Levine S;Saltzman A;    Abdominal cocoon: an animal model for a complication of peritoneal dialysis.  Peritoneal Dialysis International.  1996;16(6):613-616      

Lewis CM;Levinson DF;Wise LH;DeLisi LE;Straub RE;Hovatta I;Williams NM;Schwab SG;Pulver AE;Faraone SV;Brzustowicz LM;Kaufmann CA;Garver DL;Gurling HM;Lindholm E;Coon H;Moises HW;Byerley W;Shaw SH;Mesen A;Sherrington R;O'Neill FA;Walsh D;Kendler KS;Ekelund J;Paunio T;Lonnqvist J;Peltonen L;O'Donovan MC;Owen MJ;Wildenauer DB;Maier W;Nestadt G;Blouin JL;Antonarakis SE;Mowry BJ;Silverman JM;Crowe RR;Cloninger CR;Tsuang MT;Malaspina D;Harkavy-Friedman JM;Svrakic DM;Bassett AS;Holcomb J;Kalsi G;McQuillin A;Brynjolfson J;Sigmundsson T;Petursson H;Jazin E;Zoega T;Helgason T;    Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.  American Journal of Human Genetics.  2003;73(1):34-48      

Li BS;Veeranna;Gu J;Grant P;Pant HC;   
Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells.  European Journal of Biochemistry.  1999;262(1):211-217      

Li X;Branch CA;Ardekani BA;Bertisch H;Hicks C;DeLisi LE;    fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk.  Schizophrenia Research.  2007;96(1-3):14-24      

Li X;Branch CA;Bertisch HC;Brown K;Szulc KU;Ardekani BA;DeLisi LE;    An fMRI study of language processing in people at high genetic risk for schizophrenia.  Schizophrenia Research.  2007;91(1-3):62-72      

Liang J;Yin C;Doong H;Fang S;Peterhoff C;Nixon RA;Monteiro MJ;    Characterization of erasin (UBXD2): a new ER protein that promotes ER-associated protein degradation.  Journal of Cell Science.  2006;119(19):4011-4024      

Lim KO;Adalsteinsson E;Spielman D;Sullivan EV;Rosenbloom MJ;Pfefferbaum A;    Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.  Archives of General Psychiatry.  1998;55(4):346-352      

Lim KO;Ardekani BA;Nierenberg J;Butler PD;Javitt DC;Hoptman MJ;    Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia.  American Journal of Psychiatry.  2006;163(11):2008-2010      

Lim KO;Hedehus M;Moseley M;deCrespigny A;Sullivan EV;Pfefferbaum A;    Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging.  Archives of General Psychiatry.  1999;56(4):367-374      

Lindenmayer JP;    (non-copyrighted -attachment )
Long-acting injectable antipsychotics: focus on olanzapine pamoate.  Neuropsychiatric Disease and Treatment.  2010;6:261-267      

Lindenmayer JP;Czobor P;Volavka J;Citrome L;Sheitman B;Mcevoy JP;Cooper TB;Chakos M;Lieberman JA;    Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.  American Journal of Psychiatry.  2003;160(2):290-296      

Lindenmayer JP;McGurk SR;Mueser KT;Khan A;Wance D;Hoffman L;Wolfe R;Xie H;    A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness.  Psychiatric Services.  2008;59(3):241-247      

Lindenmayer JP;Patel R;    Olanzapine-induced ketoacidosis with diabetes mellitus.  American Journal of Psychiatry.  1999;156(9):1471      

Linster C;Menon AV;Singh CY;Wilson DA;    Odor-specific habituation arises from interaction of afferent synaptic adaptation and intrinsic synaptic potentiation in olfactory cortex.  Learning & Memory.  2009;16(7):452-459      

Lipton FR;Siegel C;Hannigan A;Samuels J;Baker S;    Tenure in supportive housing for homeless persons with severe mental illness.  Psychiatric Services.  2000;51(4):479-486      

Lipton ML;Fu KM;Branch CA;Schroeder CE;    Ipsilateral hand input to area 3b revealed by converging hemodynamic and electrophysiological analyses in macaque monkeys.  Journal of Neuroscience.  2006;26(1):180-185      

Liu-Seifert H;Kinon BJ;Tennant CJ;Sniadecki J;Volavka J;    Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone.  Neuropsychiatric Disease and Treatment.  2009;5:47-54      

Lusskin SI;Cancro R;Chuang L;Jacobson J;    Prolactin elevation with ziprasidone [letter].  American Journal of Psychiatry.  2004;161(10):1925      

Lustbader JW;Cirilli M;Lin C;Xu HW;Takuma K;Wang N;Caspersen C;Chen X;Pollak S;Chaney M;Trinchese F;Liu S;Gunn-Moore F;Lue LF;Walker DG;Kuppusamy P;Zewier ZL;Arancio O;Stern D;Yan SS;Wu H;    ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.  Science.  2004;304(5669):448-452      

Ma WJ;Zhou X;Ross LA;Foxe JJ;Parra LC;    Lip-reading aids word recognition most in moderate noise: a Bayesian explanation using high-dimensional feature space.  PLoS ONE.  2009;4(3):e4638      

Machado-Pinheiro W;Volchan E;Vila J;Dias EC;Alfradique I;de Oliveira L;Pereira MG;David IA;    Role of attention and translation in conflict resolution: implications for Stroop matching task interference.  Psychology & Neuroscience.  2010;3(2):141-150      

Madhusoodanan S;Brecher M;Brenner R;Kasckow J;Kunik M;Negron AE;Pomara N;    Risperidone in the treatment of elderly patients with psychotic disorders.  American Journal of Geriatric Psychiatry.  1999;7(2):132-138      

Magno E;Foxe JJ;Molholm S;Robertson IH;Garavan H;    The anterior cingulate and error avoidance.  Journal of Neuroscience.  2006;26(18):4769-4773      

Malone KM;Waternaux C;Haas GL;Cooper TB;Li S;Mann JJ;    Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders.  American Journal of Psychiatry.  2003;160(4):773-779      

Mannuzza S;Klein RG;Truong NL;Moulton JL;Roizen ER;Howell KH;Castellanos FX;    Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.  American Journal of Psychiatry.  2008;165(5):604-609      

Markov NT;Misery P;Falchier A;Lamy C;Vezoli J;Quilodran R;Gariel MA;Giroud P;Ercsey-Ravasz M;Pilaz LJ;Huissoud C;Barone P;Dehay C;Toroczkai Z;Van Essen DC;Kennedy H;Knoblauch K;    Weight consistency specifies regularities of macaque cortical networks.  Cerebral Cortex.  2011;21(6):1254-1272      

Martin MV;Rollins B;Sequeira PA;Mesen A;Byerley W;Stein R;Moon EA;Akil H;Jones EG;Watson SJ;Barchas J;DeLisi LE;Myers RM;Schatzberg A;Bunney WE;Vawter MP;    Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.  BMC Medical Genomics.  2009;2(1):62      

Martinez A;Hillyard SA;Dias EC;Hagler DJ;Butler PD;Guilfoyle DN;Jalbrzikowski M;Silipo G;Javitt DC;    Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging [Erratum in: J Neurosci. 2008 Sep;28(37):9319].  Journal of Neuroscience.  2008;28(30):7492-7500      

Martinez A;Ramanathan DS;Foxe JJ;Javitt DC;Hillyard SA;    The role of spatial attention in the selection of real and illusory objects.  Journal of Neuroscience.  2007;27(30):7963-7973      

Martinez D;Narendran R;Foltin RW;Slifstein M;Hwang DR;Broft A;Huang Y;Cooper TB;Fischman MW;Kleber HD;Laruelle M;    Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.  American Journal of Psychiatry.  2007;164(4):622-629      

Mastrangelo P;Mathews PM;Chishti MA;Schmidt SD;Gu Y;Yang J;Mazzella MJ;Coomaraswamy J;Horne P;Strome B;Pelly H;Levesque G;Ebeling C;Jiang Y;Nixon RA;Rozmahel R;Fraser PE;St George-Hyslop P;Carlson GA;Westaway D;    Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases.  Proceedings of the National Academy of Sciences of the United States of America.  2005;102(25):8972-8977      

Mathalon DH;Sullivan EV;Lim KO;Pfefferbaum A;    Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.  Archives of General Psychiatry.  2001;58(2):148-157      

Mathews PM;Cataldo AM;Kao BH;Rudnicki AG;Qin X;Yang JL;Jiang Y;Picciano M;Hulette C;Lippa CF;Bird TD;Nochlin D;Walter J;Haass C;Levesque L;Fraser PE;Andreadis A;Nixon RA;    Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.  Molecular Medicine.  2000;6(10):878-891      

Mathews PM;Guerra CB;Jiang Y;Grbovic OM;Kao BH;Schmidt SD;Dinakar R;Mercken M;Hille-Rehfeld A;Rohrer J;Mehta P;Cataldo AM;Nixon RA;    Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: role for altered lysosomal hydrolase distribution in beta-amyloidogenesis.  Journal of Biological Chemistry.  2002;277(7):5299-5307      

Mathews PM;Jiang Y;Schmidt SD;Grbovic OM;Mercken M;Nixon RA;    Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta -cleaved C-terminal APP fragments.  Journal of Biological Chemistry.  2002;277(39):36415-36424      

Matsuoka Y;Picciano M;Malester B;LaFrancois J;Zehr C;Daeschner JM;Olschowka JA;Fonseca MI;O'Banion MK;Tenner AJ;Lemere CA;Duff K;    Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.  American Journal of Pathology.  2001;158(4):1345-1354      

Matsuoka Y;Saito M;LaFrancois J;Saito M;Gaynor K;Olm V;Wang L;Casey E;Lu Y;Shiratori C;Lemere C;Duff K;    Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to Beta -amyloid.  Journal of Neuroscience.  2003;23(1):29-33      

McCracken JT;McGough J;Shah B;Cronin P;Hong D;Aman MG;Arnold LE;Lindsay R;Nash P;Hollway J;McDougle CJ;Posey D;Swiezy N;Kohn A;Scahill L;Martin A;Koenig K;Volkmar F;Carroll D;Lancor A;Tierney E;Ghuman J;Gonzalez NM;Grados M;Vitiello B;Ritz L;Davies M;Robinson J;McMahon D;    Risperidone in children with autism and serious behavioral problems.  New England Journal of Medicine.  2002;347(5):314-321      

Medalia A;Revheim N;    (non-copyrighted -attachment )
Dealing with cognitive dysfunction associated with psychiatric disabilities: a handbook for families and friends of individuals with psychiatric disorders.  .  2002;:      

Medalia A;Revheim N;Casey M;    The remediation of problem-solving skills in schizophrenia.  Schizophrenia Bulletin.  2001;27(2):259-267      

Mehta AD;Ulbert I;Schroeder CE;    Intermodal selective attention in monkeys. I: Distribution and timing of effects across visual areas.  Cerebral Cortex.  2000;10(4):343-358      

Mehta AD;Ulbert I;Schroeder CE;    Intermodal selective attention in monkeys. II: Physiological mechanisms of modulation.  Cerebral Cortex.  2000;10(4):359-370      

Meltzer HY;Alphs L;Green AI;Altamura AC;Anand R;Bertoldi A;Bourgeois M;Chouinard G;Islam MZ;Kane J;Krishnan R;Lindenmayer JP;Potkin S;    Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).  Archives of General Psychiatry.  2003;60(1):82-91      

Menegon A;Bonanomi D;Albertinazzi C;Lotti F;Ferrari G;Kao HT;Benfenati F;Baldelli P;Valtorta F;    Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity.  Journal of Neuroscience.  2006;26(45):11670-11681      

Meyer-Luehmann M;Coomaraswamy J;Bolmont T;Kaeser S;Schaefer C;Kilger E;Neuenschwander A;Abramowski D;Frey P;Jaton AL;Vigouret JM;Paganetti P;Walsh DM;Mathews PM;Ghiso J;Staufenbiel M;Walker LC;Jucker M;   
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.  Science.  2006;313(5794):1781-1784      

Milani D;Carmichael JD;Welkowitz J;Ferris S;Reitz RE;Danoff A;Kleinberg DL;    Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development.  Journal of Clinical Endocrinology & Metabolism.  2004;89(5):2271-2274      

Milstein G;Dugan T;    A pastoral education guide: responding to the mental health care needs of multicultural faith communities.  .  2011;:      

Milstein G;Dugan T;    A pastoral education workbook: responding to the mental health needs of multicultural faith communities.  .  2011;:      

Mishra J;Martinez A;Hillyard SA;    Cortical processes underlying sound-induced flash fusion.  Brain Research.  2008;1242:102-115      

Mishra J;Martinez A;Sejnowski TJ;Hillyard SA;    Early cross-modal interactions in auditory and visual cortex underlie a sound-induced visual illusion.  Journal of Neuroscience.  2007;27(15):4120-4131      

Mohr P;Volavka J;    Ladislav Haskovec and akathisia: 100th anniversary.  British Journal of Psychiatry.  2002;181:537      

Molholm S;Martinez A;Ritter W;Javitt DC;Foxe JJ;    The neural circuitry of pre-attentive auditory change-detection: an fMRI study of pitch and duration mismatch negativity generators.  Cerebral Cortex.  2005;15(5):545-551      

Molholm S;Ritter W;Javitt DC;Foxe JJ;    Multisensory visual-auditory object recognition in humans: a high-density electrical mapping study.  Cerebral Cortex.  2004;14(4):452-465      

Molholm S;Sehatpour P;Mehta AD;Shpaner M;Gomez-Ramirez M;Ortigue S;Dyke JP;Schwartz TH;Foxe JJ;    Audio-visual multisensory integration in superior parietal lobule revealed by human intracranial recordings.  Journal of Neurophysiology.  2006;96(2):721-729      

Monk CS;Klein RG;Telzer EH;Schroth EA;Mannuzza S;Moulton JL;Guardino M;Masten CL;Clure-Tone EB;Fromm S;Blair RJ;Pine DS;Ernst M;    Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression [Erratum in: Am J Psychiatry. 2008 Feb;165(2):266].  American Journal of Psychiatry.  2008;165(1):90-98      

Montagna LG;Ivanov MI;Bliska JB;    Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition.  Journal of Biological Chemistry.  2001;276(7):5005-5011      

Mooney LA;Perera FP;Van Bennekum AM;Blaner WS;Karkoszka J;Covey L;Hsu Y;Cooper TB;Frenkel K;    Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers.  Cancer Epidemiology, Biomarkers & Prevention.  2001;10(6):641-648      

Morales-Corraliza J;Mazzella MJ;Berger JD;Diaz NS;Choi JH;Levy E;Matsuoka Y;Planel E;Mathews PM;    In vivo turnover of tau and APP Metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice.  PLoS ONE.  2009;4(9):e7134      

Moretti P;Levenson JM;Battaglia F;Atkinson R;Teague R;Antalffy B;Armstrong D;Arancio O;Sweatt JD;Zoghbi HY;    Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.  Journal of Neuroscience.  2006;26(1):319-327      

Moriceau S;Raineki C;Holman JD;Holman JG;Sullivan RM;    Enduring neurobehavioral effects of early life trauma mediated through learning and corticosterone suppression.  Frontiers in Behavioral Neuroscience.  2009;3:22      

Mosconi L;Brys M;Switalski R;Mistur R;Glodzik L;Pirraglia E;Tsui W;De Santi S;de Leon MJ;    Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.  Proceedings of the National Academy of Sciences of the United States of America.  2007;104(48):19067-19072      

Mosconi L;De Santi S;Brys M;Tsui WH;Pirraglia E;Glodzik-Sobanska L;Rich KE;Switalski R;Mehta PD;Pratico D;Zinkowski R;Blennow K;de Leon MJ;    Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.  Biological Psychiatry.  2008;63(6):609-618      

Murray MM;Foxe DM;Javitt DC;Foxe JJ;    Setting boundaries: brain dynamics of modal and amodal illusory shape completion in humans.  Journal of Neuroscience.  2004;24(31):6898-6903      

Murray MM;Imber ML;Javitt DC;Foxe JJ;    Boundary completion is automatic and dissociable from shape discrimination.  Journal of Neuroscience.  2006;26(46):12043-12054      

Murray MM;Molholm S;Michel CM;Heslenfeld DJ;Ritter W;Javitt DC;Schroeder CE;Foxe JJ;    Grabbing your ear: rapid auditory-somatosensory multisensory interactions in low-level sensory cortices are not constrained by stimulus alignment.  Cerebral Cortex.  2005;15(7):963-974      

Murray MM;Wylie GR;Higgins BA;Javitt DC;Schroeder CE;Foxe JJ;    The spatiotemporal dynamics of illusory contour processing: combined high-density electrical mapping, source analysis, and functional magnetic resonance imaging.  Journal of Neuroscience.  2002;22(12):5055-5073      

Murrey HE;Gama CI;Kalovidouris SA;Luo WI;Driggers EM;Porton B;Hsieh-Wilson LC;    Protein fucosylation regulates synapsin Ia/Ib expression and neuronal morphology in primary hippocampal neurons.  Proceedings of the National Academy of Sciences of the United States of America.  2006;103(1):21-26      

Musacchia G;Van Atteveldt N;Sehatpour P;Zion-Golumbic E;Lakatos P;Gaspar PA;Schroeder CE;Javitt D;    A combined EEG-fMRI investigation of 'rhythmic' versus 'vigilant' processing I: neural dynamics.  Frontiers in Human Neuroscience.  2011;Conference Abstract:      

Narendran R;Frankle WG;Keefe R;Gil R;Martinez D;Slifstein M;Kegeles LS;Talbot PS;Huang Y;Hwang DR;Khenissi L;Cooper TB;Laruelle M;Abi-Dargham A;    Altered prefrontal dopaminergic function in chronic recreational ketamine users.  American Journal of Psychiatry.  2005;162(12):2352-2359      

Neeman G;Blanaru M;Bloch B;Kremer I;Ermilov M;Javitt DC;Heresco-Levy U;    Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type.  American Journal of Psychiatry.  2005;162(9):1738-1740      

Nicoletti JN;Shah SK;McCloskey DP;Goodman JH;Elkady A;Atassi H;Hylton D;Rudge JS;Scharfman HE;Croll SD;    Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus.  Neuroscience.  2008;151(1):232-241      

Nierenberg J;Salisbury DF;Levitt JJ;David EA;McCarley RW;Shenton ME;    Reduced left angular gyrus volume in first-episode schizophrenia.  American Journal of Psychiatry.  2005;162(8):1539-1541      

Ninan I;Arancio O;    Presynaptic CaMKII is necessary for synaptic plasticity in cultured hippocampal neurons.  Neuron.  2004;42(1):129-141      

Nixon RA;    Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up.  American Journal of Pathology.  2004;164(3):757-761      

Nixon RA;    Autophagy, amyloidogenesis and Alzheimer disease.  Journal of Cell Science.  2007;120(Pt 23):4081-4091      

Noble W;Olm V;Takata K;Casey E;Mary O;Meyerson J;Gaynor K;LaFrancois J;Wang L;Kondo T;Davies P;Burns M;Veeranna;Nixon R;Dickson D;Matsuoka Y;Ahlijanian M;Lau LF;Duff K;    Cdk5 is a key factor in tau aggregation and tangle formation in vivo.  Neuron.  2003;38(4):555-565      

Noble W;Planel E;Zehr C;Olm V;Meyerson J;Suleman F;Gaynor K;Wang L;LaFrancois J;Feinstein B;Burns M;Krishnamurthy P;Wen Y;Bhat R;Lewis J;Dickson D;Duff K;    Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.  Proceedings of the National Academy of Sciences of the United States of America.  2005;102(19):6990-6995      

Nolan KA;Bilder RM;Lachman HM;Volavka J;    Catechol O-methyltransferase val(158)met polymorphism in schizophrenia: differential effects of val and met alleles on cognitive stability and flexibility.  American Journal of Psychiatry.  2004;161(2):359-361      

Nolan KA;Czobor P;Roy BB;Platt MM;Shope CB;Citrome LL;Volavka J;    Characteristics of assaultive behavior among psychiatric inpatients.  Psychiatric Services.  2003;54(7):1012-1016      

Nolan KA;Volavka J;Mohr P;Czobor P;    Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorder.  Psychiatric Services.  1999;50(6):787-792      

Ohno M;Cole SL;Yasvoina M;Zhao J;Citron M;Berry R;Disterhoft JF;Vassar R;    BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice.  Neurobiology of Disease.  2007;26(1):134-145      

Ohshima T;Ogawa M;Veeranna;Hirasawa M;Longenecker G;Ishiguro K;Pant HC;Brady RO;Kulkarni AB;Mikoshiba K;    Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.  Proceedings of the National Academy of Sciences of the United States of America.  2001;98(5):2764-2769      

Oquendo MA;Echavarria G;Galfalvy HC;Grunebaum MF;Burke A;Barrera A;Cooper TB;Malone KM;Mann JJ;    Lower cortisol levels in depressed patients with comorbid post-traumatic stress disorder.  Neuropsychopharmacology.  2003;28(3):591-598      

Oquendo MA;Placidi GP;Malone KM;Campbell C;Keilp J;Brodsky B;Kegeles LS;Cooper TB;Parsey RV;Van Heertum RL;Mann JJ;    Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.  Archives of General Psychiatry.  2003;60(1):14-22      

Ortega S;Ittmann M;Tsang SH;Ehrlich M;Basilico C;    Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2.  Proceedings of the National Academy of Sciences of the United States of America.  1998;95(10):5672-5677      

Oslin DW;Streim JE;Katz IR;Smith BD;DiFilippo SD;Ten Have TR;Cooper T;    Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients.  American Journal of Geriatric Psychiatry.  2000;8(2):141-149      

Pawlik M;Otero DA;Park M;Fischer WH;Levy E;Saitoh T;    Proteins that bind to the RERMS region of beta amyloid precursor protein.  Biochemical & Biophysical Research Communications.  2007;355(4):907-912      

Pedrini S;Carter TL;Prendergast G;Petanceska S;Ehrlich ME;Gandy S;    Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK.  PLoS Medicine.  2005;2(1):e18      

Pedrosa E;Nolan KA;Stefanescu R;Hershcovitz P;Novak T;Zukov I;Stopkova P;Lachman HM;    Analysis of a promoter polymorphism in the SMDF neuregulin 1 isoform in schizophrenia [erratum in Neuropsychobiology. 2009;60(2):72].  Neuropsychobiology.  2009;59(4):205-212      

Pelton GH;Devanand DP;Bell K;Marder K;Marston K;Liu X;Cooper TB;    Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol.  American Journal of Geriatric Psychiatry.  2003;11(2):186-193      

Peng S;Garzon DJ;Marchese M;Klein W;Ginsberg SD;Francis BM;Mount HT;Mufson EJ;Salehi A;Fahnestock M;    Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.  Journal of Neuroscience.  2009;29(29):9321-9329      

Perrin MA;Chen H;Sandberg DE;Malaspina D;Brown AS;    Growth trajectory during early life and risk of adult schizophrenia.  British Journal of Psychiatry.  2007;191(6):512-520      

Perrin MA;Digrande L;Wheeler K;Thorpe L;Farfel M;Brackbill R;    Differences in PTSD prevalence and associated risk factors among World Trade Center disaster rescue and recovery workers.  American Journal of Psychiatry.  2007;164(9):1385-1394      

Petersen RC;Thomas RG;Grundman M;Bennett D;Doody R;Ferris S;Galasko D;Jin S;Kaye J;Levey A;Pfeiffer E;Sano M;van Dyck CH;Thal LJ;    Vitamin E and donepezil for the treatment of mild cognitive impairment.  New England Journal of Medicine.  2005;352(23):2379-2388      

Petrone A;Battaglia F;Wang C;Dusa A;Su J;Zagzag D;Bianchi R;Casaccia-Bonnefil P;Arancio O;Sap J;    Receptor protein tyrosine phosphatase alpha is essential for hippocampal neuronal migration and long-term potentiation.  EMBO Journal.  2003;22(16):4121-4131      

Pfefferbaum A;Adalsteinsson E;Spielman D;Sullivan EV;Lim KO;    In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.  Archives of General Psychiatry.  1999;56(2):185-192      

Pfefferbaum A;Sullivan EV;Rosenbloom MJ;Mathalon DH;Lim KO;    A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval.  Archives of General Psychiatry.  1998;55(10):905-912      

Pfeifer M;Boncristiano S;Bondolfi L;Stalder A;Deller T;Staufenbiel M;Mathews PM;Jucker M;    Cerebral hemorrhage after passive anti-Abeta immunotherapy.  Science.  2002;298(5597):1379      

Phinney AL;Drisaldi B;Schmidt SD;Lugowski S;Coronado V;Liang Y;Horne P;Yang J;Sekoulidis J;Coomaraswamy J;Chishti MA;Cox DW;Mathews PM;Nixon RA;Carlson GA;George-Hyslop P;Westaway D;    In vivo reduction of amyloid-beta by a mutant copper transporter.  Proceedings of the National Academy of Sciences of the United States of America.  2003;100(24):14193-14198      

Pine DS;Klein RG;Roberson-Nay R;Mannuzza S;Moulton JL;Woldehawariat G;Guardino M;    Response to 5% carbon dioxide in children and adolescents: relationship to panic disorder in parents and anxiety disorders in subjects.  Archives of General Psychiatry.  2005;62(1):73-80      

Pitts MA;Martinez A;Hillyard SA;    When and where is binocular rivalry resolved in the visual cortex?.  Journal of Vision.  2010;10(14):      

Pitts MA;Martinez A;Stalmaster C;Nerger JL;Hillyard SA;    Neural generators of ERPs linked with Necker cube reversals.  Psychophysiology.  2009;46(4):694-702      

Planel E;Krishnamurthy P;Miyasaka T;Liu L;Herman M;Kumar A;Bretteville A;Figueroa HY;Haung YW;Whittington RA;Davies P;Takashima A;Nixon RA;Duff KE;    Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo.  Journal of Neuroscience.  2008;28(48):12798-12807      

Pomara N;Belzer K;Sidtis JJ;    Deleterious CNS effects of the APOE epsilon4 allele in individuals with HIV-1 infection may be age-dependent [letter].  Proceedings of the National Academy of Sciences of the United States of America.  2008;105(41):E65-E68      

Pomara N;Greenberg WM;Branford MD;Doraiswamy PM;    Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update.  Psychopharmacology Bulletin.  2003;37(2):120-134      

Pomara N;Willoughby L;Wesnes K;Greenblatt DJ;Sidtis JJ;    Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.  Archives of General Psychiatry.  2005;62(2):209-216      

Pomara N;Willoughby LM;Ritchie JC;Sidtis JJ;Greenblatt DJ;Nemeroff CB;    Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly.  Neuropsychopharmacology.  2004;29(3):605-611      

Pomara N;Willoughby LM;Wesnes K;Sidtis JJ;    Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study.  Neuropsychopharmacology.  2004;29(2):403-409      

Prichep LS;Gugino LD;John ER;Chabot RJ;Howard B;Merkin H;Tom ML;Wolter S;Rausch L;Kox WJ;    The Patient State Index as an indicator of the level of hypnosis under general anaesthesia.  British Journal of Anaesthesia.  2004;92(3):393-399      

Psychoyos D;Hungund B;Finnell RH;    Endocannabinoid signaling in early neurodevelopment: effect of gestational D 9-THC exposure.  The Open Neuropsychopharmacology Journal.  2009;2:64-76      

Qian Y;Lei G;Castellanos FX;Forssberg H;Heijtz RD;    (non-copyrighted -attachment )
Deficits in fine motor skills in a genetic animal model of ADHD.  Behavioral and Brain Functions.  2010;6:51      

Rabinowicz EF;Silipo G;Goldman R;Javitt DC;    Auditory sensory dysfunction in schizophrenia - Imprecision or distractibility?.  Archives of General Psychiatry.  2000;57(12):1149-1155      

Raineki C;Pickenhagen A;Roth TL;Babstock DM;McLean JH;Harley CW;Lucion AB;Sullivan RM;    (non-copyrighted -attachment )
The neurobiology of infant maternal odor learning.  Brazilian Journal of Medical and Biological Research.  2010;43(10):914-919      

Rao MV;Campbell J;Yuan A;Kumar A;Gotow T;Uchiyama Y;Nixon RA;    The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate.  Journal of Cell Biology.  2003;163(5):1021-1031      

Rao MV;Engle LJ;Mohan PS;Yuan A;Qiu D;Cataldo A;Hassinger L;Jacobsen S;Lee VM;Andreadis A;Julien JP;Bridgman PC;Nixon RA;    Myosin Va binding to neurofilaments is essential for correct myosin Va distribution and transport and neurofilament density.  Journal of Cell Biology.  2002;159(2):279-290      

Rao MV;Garcia ML;Miyazaki Y;Gotow T;Yuan A;Mattina S;Ward CM;Calcutt NA;Uchiyama Y;Nixon RA;Cleveland DW;    Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport.  Journal of Cell Biology.  2002;158(4):681-693      

Rao MV;Mohan PS;Kumar A;Yuan A;Montagna L;Campbell J;Veeranna;Espreafico EM;Julien JP;Nixon RA;    The myosin Va head domain binds to the neurofilament-L rod and modulates endoplasmic reticulum (ER) content and distribution within axons.  PLoS ONE.  2011;6(2):e17087      

Rao MV;Mohan PS;Peterhoff CM;Yang DS;Schmidt SD;Stavrides PH;Campbell J;Chen Y;Jiang Y;Paskevich PA;Cataldo AM;Haroutunian V;Nixon RA;    Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.  Journal of Neuroscience.  2008;28(47):12241-12254      

Reid MS;Flammino F;Howard B;Nilsen D;Prichep LS;    Topographic imaging of quantitative EEG in response to smoked cocaine self-administration in humans.  Neuropsychopharmacology.  2006;31(4):872-884      

Reisberg B;Doody R;Stoffler A;Schmitt F;Ferris S;Mobius HJ;    Memantine in moderate-to-severe Alzheimer's disease.  New England Journal of Medicine.  2003;348(14):1333-1341      

Reisberg B;Doody R;Stoffler A;Schmitt F;Ferris S;Mobius HJ;    A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.  Archives of Neurology.  2006;63(1):49-54      

Revheim N;Javitt DC;    Reading disability goes beyond consent forms.  Psychiatric Services.  2007;58(4):566      

Revheim N;Medalia A;    The Independent Living Scales as a measure of functional outcome for schizophrenia.  Psychiatric Services.  2004;55(9):1052-1054      

Richardson MA;Bevans ML;Read LL;Chao HM;Clelland JD;Suckow RF;Maher TJ;Citrome L;    Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.  American Journal of Psychiatry.  2003;160(6):1117-1124      

Ritter W;De Sanctis P;Molholm S;Javitt DC;Foxe JJ;    Preattentively grouped tones do not elicit MMN with respect to each other.  Psychophysiology.  2006;43(5):423-430      

Robinson D;Woerner MG;Alvir JM;Bilder R;Goldman R;Geisler S;Koreen A;Sheitman B;Chakos M;Mayerhoff D;Lieberman JA;    Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.  Archives of General Psychiatry.  1999;56(3):241-247      

Robinson DG;Woerner MG;Alvir JM;Geisler S;Koreen A;Sheitman B;Chakos M;Mayerhoff D;Bilder R;Goldman R;Lieberman JA;    Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.  American Journal of Psychiatry.  1999;156(4):544-549      

Ross LA;Saint-Amour D;Leavitt VM;Javitt DC;Foxe JJ;    Do you see what I am saying? Exploring visual enhancement of speech comprehension in noisy environments.  Cerebral Cortex.  2007;17(5):1147-1153      

Rozmahel R;Mount HT;Chen F;Nguyen V;Huang J;Erdebil S;Liauw J;Yu G;Hasegawa H;Gu Y;Song YQ;Schmidt SD;Nixon RA;Mathews PM;Bergeron C;Fraser P;Westaway D;George-Hyslop P;    Alleles at the Nicastrin locus modify presenilin 1- deficiency phenotype.  Proceedings of the National Academy of Sciences of the United States of America.  2002;99(22):14452-14457      

Rubinsztein DC;DiFiglia M;Heintz N;Nixon RA;Qin ZH;Ravikumar B;Stefanis L;Tolkovsky A;    Autophagy and its possible roles in nervous system diseases, damage and repair.  Autophagy.  2005;1(1):11-22      

Rundshagen I;Schroder T;Prichep LS;John ER;Kox WJ;    Changes in cortical electrical activity during induction of anaesthesia with thiopental/fentanyl and tracheal intubation: a quantitative electroencephalographic analysis.  British Journal of Anaesthesia.  2004;92(1):33-38      

Rusinek H;De Santi S;Frid D;Tsui WH;Tarshish CY;Convit A;de Leon MJ;    Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging.  Radiology.  2003;229(3):691-696      

Sackeim HA;Haskett RF;Mulsant BH;Thase ME;Mann JJ;Pettinati HM;Greenberg RM;Crowe RR;Cooper TB;Prudic J;    Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.  JAMA.  2001;285(10):1299-1307      

Sadowski M;Pankiewicz J;Scholtzova H;Ripellino JA;Li Y;Schmidt SD;Mathews PM;Fryer JD;Holtzman DM;Sigurdsson EM;Wisniewski T;    A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.  American Journal of Pathology.  2004;165(3):937-948      

Saint-Amour D;De Sanctis P;Molholm S;Ritter W;Foxe JJ;    Seeing voices: high-density electrical mapping and source-analysis of the multisensory mismatch negativity evoked during the McGurk illusion.  Neuropsychologia.  2007;45(3):587-597      

Sambamurti K;Sevlever D;Koothan T;Refolo LM;Pinnix I;Gandhi S;Onstead L;Younkin L;Prada CM;Yager D;Ohyagi Y;Eckman CB;Rosenberry TL;Younkin SG;    Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein.  Journal of Biological Chemistry.  1999;274(38):26810-26814      

Sanchez I;Hassinger L;Sihag RK;Cleveland DW;Mohan P;Nixon RA;    Local control of neurofilament accumulation during radial growth of myelinating axons in vivo. Selective role of site-specific phosphorylation.  Journal of Cell Biology.  2000;151(5):1013-1024      

Sano Y;Nakaya T;Pedrini S;Takeda S;Iijima-Ando K;Iijima K;Mathews PM;Itohara S;Gandy S;Suzuki T;    Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP.  PLoS ONE.  2006;1:e51      

Santarelli L;Saxe M;Gross C;Surget A;Battaglia F;Dulawa S;Weisstaub N;Lee J;Duman R;Arancio O;Belzung C;Hen R;    Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.  Science.  2003;301(5634):805-809      

Santor DA;scher-Svanum H;Lindenmayer JP;Obenchain RL;    Item response analysis of the Positive and Negative Syndrome Scale.  BMC Psychiatry.  2007;7(1):66      

Sasaki T;Gotow T;Shiozaki M;Sakaue F;Saito T;Julien JP;Uchiyama Y;Hisanaga S;    Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants.  Human Molecular Genetics.  2006;15(6):943-952      

Saura CA;Choi SY;Beglopoulos V;Malkani S;Zhang D;Rao BS;Chattarji S;Kelleher RJ;Kandel ER;Duff K;Kirkwood A;Shen J;    Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration.  Neuron.  2004;42(1):23-36      

Scharfman HE;    (non-copyrighted -attachment )
Seizing an opportunity: broader definitions of epilepsy may lead to better treatments.  Cerebrum.  2010;2010:      

Scharfman HE;    The neurobiology of epilepsy.  Current Neurology & Neuroscience Reports.  2007;7(4):348-354      

Scharfman HE;    The CA3 'backprojection' to the dentate gyrus.  Progress in Brain Research.  2007;163:627-637      

Scharfman HE;Hintz TM;Gomez J;Stormes KA;Barouk S;Malthankar-Phatak GH;McCloskey DP;Luine VN;Maclusky NJ;    Changes in hippocampal function of ovariectomized rats after sequential low doses of estradiol to simulate the preovulatory estrogen surge.  European Journal of Neuroscience.  2007;26(9):2595-2612      

Schechter I;Butler PD;Saperstein AM;Revheim N;Silipo G;Zemon V;Javitt DC;    M-pathway deficits in schizophrenia: VEPs, contrast sensitivity and functional outcome.  Investigative Ophthalmology & Visual Science.  2002;43:E-Abstract 1810      

Schiller D;Levy I;Niv Y;Ledoux JE;Phelps EA;    From fear to safety and back: reversal of fear in the human brain.  Journal of Neuroscience.  2008;28(45):11517-11525      

Schoenfeld MA;Hopf JM;Martinez A;Mai HM;Sattler C;Gasde A;Heinze HJ;Hillyard SA;    Spatio-temporal analysis of feature-based attention.  Cerebral Cortex.  2007;17(10):2468-2477      

Schoenfeld MA;Tempelmann C;Martinez A;Hopf JM;Sattler C;Heinze HJ;Hillyard SA;    Dynamics of feature binding during object-selective attention.  Proceedings of the National Academy of Sciences of the United States of America.  2003;100(20):11806-11811      

Schroeder CE;Lindsley RW;Specht C;Marcovici A;Smiley JF;Javitt DC;    Somatosensory input to auditory association cortex in the macaque monkey.  Journal of Neurophysiology.  2001;85(3):1322-1327      

Schroeder CE;Mehta AD;Givre SJ;    A spatiotemporal profile of visual system activation revealed by current source density analysis in the awake macaque.  Cerebral Cortex.  1998;8(7):575-592      

Schroeder CE;Seto S;Garraghty PE;    Emergence of radial nerve dominance in median nerve cortex after median nerve transection in an adult squirrel monkey.  Journal of Neurophysiology.  1997;77(1):522-526      

Sederer LI;    Crime in the military - madness, badness, and survival.  Psychiatric Times.  2011;28(10):      

Sehatpour P;Molholm S;Schwartz TH;Mahoney JR;Mehta AD;Javitt DC;Stanton PK;Foxe JJ;    A human intracranial study of long-range oscillatory coherence across a frontal-occipital-hippocampal brain network during visual object processing.  Proceedings of the National Academy of Sciences of the United States of America.  2008;105(11):4399-4404      

Seidman SN;Araujo AB;Roose SP;Devanand DP;Xie S;Cooper TB;McKinlay JB;    Low testosterone levels in elderly men with dysthymic disorder.  American Journal of Psychiatry.  2002;159(3):456-459      

Senkowski D;Molholm S;Gomez-Ramirez M;Foxe JJ;    Oscillatory beta activity predicts response speed during a multisensory audiovisual reaction time task: a high-density electrical mapping study.  Cerebral Cortex.  2006;16(11):1556-1565      

Serebruany VL;Suckow RF;Cooper TB;O'connor CM;Malinin AI;Krishnan KR;van Zyl LT;Lekht V;Glassman AH;Sertraline Antidepressant Heart Attack Randomized Trial;    Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.  American Journal of Psychiatry.  2005;162(6):1165-1170      

Serper MR;Chou JC;Allen MH;Czobor P;Cancro R;    Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentation.  Schizophrenia Bulletin.  1999;25(2):387-394      

Shah AS;Bressler SL;Knuth KH;Ding M;Mehta AD;Ulbert I;Schroeder CE;    Neural dynamics and the fundamental mechanisms of event-related brain potentials.  Cerebral Cortex.  2004;14(5):476-483      

Sharma P;Veeranna;Sharma M;Amin ND;Sihag RK;Grant P;Ahn N;Kulkarni AB;Pant HC;    Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway.  Journal of Biological Chemistry.  2002;277(1):528-534      

Shaw P;Gornick M;Lerch J;Addington A;Seal J;Greenstein D;Sharp W;Evans A;Giedd JN;Castellanos FX;Rapoport JL;    Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.  Archives of General Psychiatry.  2007;64(8):921-931      

Shen J;Petersen KF;Behar KL;Brown P;Nixon TW;Mason GF;Petroff OAC;Shulman GI;Shulman RG;Rothman DL;    Determination of the rate of the glutamate glutamine cycle in the human brain by in vivo C-13 NMR.  Proceedings of the National Academy of Sciences of the United States of America.  1999;96(14):8235-8240      

Shern DL;Jones K;Chen HJ;Jordan N;Ramoni-Perazzi J;Boothroyd RA;    Medicaid managed care and the distribution of societal costs for persons with severe mental illness.  American Journal of Psychiatry.  2008;165(2):254-260      

Shin J;Tsui W;Li Y;Lee SY;Kim SJ;Cho SJ;Kim YB;de Leon MJ;    Resting-state glucose metabolism level is associated with the regional pattern of amyloid pathology in Alzheimer's disease.  International Journal of Alzheimer's Disease.  2011;2011:759780      

Siegel CE;Laska E;Meisner M;    Estimating capacity requirements for mental health services after a disaster has occurred: a call for new data.  American Journal of Public Health.  2004;94(4):582-585      

Siegel CE;Samuels J;Tang DI;Berg I;Jones K;Hopper K;    Tenant outcomes in supported housing and community residences in New York City.  Psychiatric Services.  2006;57(7):982-991      

Siegmund SV;Qian T;de Minicis S.;Harvey-White J;Kunos G;Vinod KY;Hungund B;SHungund B;Schwabe RF;    The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species.  FASEB Journal.  2007;21(11):2798-2806      

Siksou L;Rostaing P;Lechaire JP;Boudier T;Ohtsuka T;Fejtova A;Kao HT;Greengard P;Gundelfinger ED;Triller A;Marty S;    Three-dimensional architecture of presynaptic terminal cytomatrix.  Journal of Neuroscience.  2007;27(26):6868-6877      

Silverman DH;Small GW;Chang CY;Lu CS;Kung De Aburto MA;Chen W;Czernin J;Rapoport SI;Pietrini P;Alexander GE;Schapiro MB;Jagust WJ;Hoffman JM;Welsh-Bohmer KA;Alavi A;Clark CM;Salmon E;de Leon MJ;Mielke R;Cummings JL;Kowell AP;Gambhir SS;Hoh CK;Phelps ME;    Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.  JAMA.  2001;286(17):2120-2127      

Simon Z;Vigh-Smeller M;Peragovics A;Csukly G;Zahoranszky-Kohalmi G;Rauscher AA;Jelinek B;Hari P;Bitter I;Malnasi-Csizmadia A;Czobor P;    (non-copyrighted -attachment )
Relating the shape of protein binding sites to binding affinity profiles: is there an association?.  BMC Structural Biology.  2010;10:32      

Simpson HB;Foa EB;Liebowitz MR;Ledley DR;Huppert JD;Cahill S;Vermes D;Schmidt AB;Hembree E;Franklin M;Campeas R;Hahn CG;Petkova E;    A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.  American Journal of Psychiatry.  2008;165(5):621-630      

Singleton AB;Hall R;Ballard CG;Perry RH;Xuereb JH;Rubinsztein DC;Tysoe C;Mathews P;Cordell B;Kumar-Singh S;De Jonghe C;Cruts M;Van Broeckhoven C;Morris CM;    Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.  Brain.  2000;123(12):2467-2474      

Smiley JF;Rosoklija G;Mancevski B;Mann JJ;Dwork AJ;Javitt DC;    Altered volume and hemispheric asymmetry of the superficial cortical layers in the schizophrenia planum temporale.  European Journal of Neuroscience.  2009;30(3):449-463      

Smith GS;Dewey SL;Brodie JD;Logan J;Vitkun SA;Simkowitz P;Schloesser R;Alexoff DA;Hurley A;Cooper T;Volkow ND;    Serotonergic modulation of dopamine measured with [C-11]raclopride and PET in normal human subjects.  American Journal of Psychiatry.  1997;154(4):490-496      

Smith GS;Schloesser R;Brodie JD;Dewey SL;Logan J;Vitkun SA;Simkowitz P;Hurley A;Cooper T;Volkow ND;Cancro R;    Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and C-11-raclopride in normal human subjects.  Neuropsychopharmacology.  1998;18(1):18-25      

Smith JJ;Shionoya K;Sullivan RM;Wilson DA;    Auditory stimulation dishabituates olfactory responses via noradrenergic cortical modulation.  Neural Plasticity.  2009;2009:754014      

Sperdin HF;Cappe C;Foxe JJ;Murray MM;    Early, low-level auditory-somatosensory multisensory interactions impact reaction time speed.  Frontiers in Integrative Neuroscience.  2009;3:2      

Srabstein JC;Leventhal BL;    (non-copyrighted -attachment )
Prevention of bullying-related morbidity and mortality: a call for public health policies.  Bulletin of the World Health Organization.  2010;88(6):403      

Stang E;Guerra CB;Amaya M;Paterson Y;Bakke O;Mellins ED;    DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.  Journal of Immunology.  1998;160(10):4696-4707      

Stark DE;Margulies DS;Shehzad ZE;Reiss P;Kelly AM;Uddin LQ;Gee DG;Roy AK;Banich MT;Castellanos FX;Milham MP;    Regional variation in interhemispheric coordination of intrinsic hemodynamic fluctuations.  Journal of Neuroscience.  2008;28(51):13754-13764      

Steadman HJ;Gounis K;Dennis D;Hopper K;Roche B;Swartz M;Robbins PC;    Assessing the New York City involuntary outpatient commitment pilot program.  Psychiatric Services.  2001;52(3):330-336      

Steadman HJ;Gounis K;Dennis D;Hopper K;Roche B;Swartz M;Robbins PC;    Assessing the New York City involuntary outpatient treatment program [reply].  Psychiatric Services.  2001;52(11):1533-1534      

Stein DJ;Cloitre M;Nemeroff CB;Nutt DJ;Seedat S;Shalev AY;Wittchen HU;Zohar J;    Cape Town consensus on posttraumatic stress disorder.  CNS Spectrums.  2009;14(1 Suppl 1):52-58      

Steiner H;Duff K;Capell A;Romig H;Grim MG;Lincoln S;Hardy J;Yu X;Picciano M;Fechteler K;Citron M;Kopan R;Pesold B;Keck S;Baader M;Tomita T;Iwatsubo T;Baumeister R;Haass C;    A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling.  Journal of Biological Chemistry.  1999;274(40):28669-28673      

Streim JE;Oslin DW;Katz IR;Smith BD;DiFilippo S;Cooper TB;Ten Have T;    Drug treatment of depression in frail elderly nursing home residents.  American Journal of Geriatric Psychiatry.  2000;8(2):150-159      

Sullivan EV;Deshmukh A;Desmond JE;Mathalon DH;Rosenbloom MJ;Lim KO;Pfefferbaum A;    Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia.  Archives of General Psychiatry.  2000;57(9):894-902      

Sullivan EV;Lim KO;Mathalon D;Marsh L;Beal DM;Harris D;Hoff AL;Faustman WO;Pfefferbaum A;    A profile of cortical gray matter volume deficits characteristic of schizophrenia.  Cerebral Cortex.  1998;8(2):117-124      

Szeszko PR;Ardekani BA;Ashtari M;Kumra S;Robinson DG;Sevy S;Gunduz-Bruce H;Malhotra AK;Kane JM;Bilder RM;Lim KO;    White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study.  American Journal of Psychiatry.  2005;162(3):602-605      

Szeszko PR;Ardekani BA;Ashtari M;Malhotra AK;Robinson DG;Bilder RM;Lim KO;    White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study.  Archives of General Psychiatry.  2005;62(7):782-790      

Szeszko PR;Robinson D;Alvir JM;Bilder RM;Lencz T;Ashtari M;Wu H;Bogerts B;    Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder.  Archives of General Psychiatry.  1999;56(10):913-919      

Szeszko PR;Strous RD;Goldman RS;Ashtari M;Knuth KH;Lieberman JA;Bilder RM;    Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia.  American Journal of Psychiatry.  2002;159(2):217-226      

Taintor Z;    Book review: Managed Behavioral Healthcare Handbook.  Psychiatric Services.  2002;53(11):1481      

Taintor Z;    Multimedia reviews: multimedia convergence for clinicians.  Psychiatric Services.  2003;54(12):1584-5, 1588      

Taintor Z;    Book review: e-Therapy: Case Studies, Guiding Principles, and the Clinical Potential of the Internet.  Psychiatric Services.  2003;54(10):1422      

Taintor Z;    Book review: Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill.  Psychiatric Services.  2003;54(1):112-113      

Taintor Z;    Book review: Human Services Technology: Innovations in Practice and Education.  Psychiatric Services.  2004;55(4):460-461      

Takeuchi A;Irizarry MC;Duff K;Saido TC;Hsiao AK;Hasegawa M;Mann DM;Hyman BT;Iwatsubo T;    Age-related amyloid beta deposition in transgenic mice overexpressing both alzheimer mutant presenilin 1 and amyloid beta precursor protein swedish mutant is not associated with global neuronal loss [erratum in Am J Pathol 2000 Oct;157(4):1413].  American Journal of Pathology.  2000;157(1):331-339      

Tanaka T;Veeranna;Ohshima T;Rajan P;Amin ND;Cho A;Sreenath T;Pant HC;Brady RO;Kulkarni AB;    Neuronal cyclin-dependent kinase 5 activity is critical for survival.  Journal of Neuroscience.  2001;21(2):550-558      

Tarpey T;Yun D;Petkova E;    Model misspecification: finite mixture or homogeneous?.  Statistical Modelling.  2008;8(2):199-218      

Terleph TA;Klein RG;Roberson-Nay R;Mannuzza S;Moulton JL;Woldehawariat G;Guardino M;Pine DS;    Stress responsivity and HPA axis activity in juveniles: results from a home-based CO2 inhalation study.  American Journal of Psychiatry.  2006;163(4):738-740      

Terman JS;Terman M;Lo ES;Cooper TB;    Circadian time of morning light administration and therapeutic response in winter depression.  Archives of General Psychiatry.  2001;58(1):69-75      

Tesseur I;Zou K;Esposito L;Bard F;Berber E;Can JV;Lin AH;Crews L;Tremblay P;Mathews P;Mucke L;Masliah E;Wyss-Coray T;    Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.  Journal of Clinical Investigation.  2006;116(11):3060-3069      

Thal LJ;Ferris SH;Kirby L;Block GA;Lines CR;Yuen E;Assaid C;Nessly ML;Norman BA;Baranak CC;Reines SA;    A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.  Neuropsychopharmacology.  2005;30(6):1204-1215      

The Research Unit on Pediatric Psychopharmacology Anxiety Study Group;    Fluvoxamine for the treatment of anxiety disorders in children and adolescents..  New England Journal of Medicine.  2001;344(17):1279-1285      

Thompson DM;Guidotti A;DiBella M;Costa E;    7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S- dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.  Proceedings of the National Academy of Sciences of the United States of America.  1995;92(17):7667-7671      

Tiihonen J;Walhbeck K;Lonnqvist J;Klaukka T;Ioannidis JP;Volavka J;Haukka J;    Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.  BMJ.  2006;333(7561):224-227      

Tizon B;Sahoo S;Yu H;Gauthier S;Kumar AR;Mohan P;Figliola M;Pawlik M;Grubb A;Uchiyama Y;Bandyopadhyay U;Cuervo AM;Nixon RA;Levy E;    (non-copyrighted -attachment )
Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines.  PLoS ONE.  2010;5(3):e9819      

Tohen M;Calabrese JR;Sachs GS;Banov MD;Detke HC;Risser R;Baker RW;Chou JC;Bowden CL;    Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.  American Journal of Psychiatry.  2006;163(2):247-256      

Tremeau F;Citrome L;    Optimizing dosing in atypical neuroleptic monotherapy.  Dialogues in Clinical Neuroscience.  2002;4(4):438-443      

Tremeau F;Malaspina D;Duval F;Correa H;Hager-Budny M;Coin-Bariou L;Macher JP;Gorman JM;    Facial expressiveness in patients with schizophrenia compared to depressed patients and nonpatient comparison subjects.  American Journal of Psychiatry.  2005;162(1):92-101      

Trinchese F;Fa' M;Liu S;Zhang H;Hidalgo A;Schmidt SD;Yamaguchi H;Yoshii N;Mathews PM;Nixon RA;Arancio O;    Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease.  Journal of Clinical Investigation.  2008;118(8):2796-2807      

Turkoz I;Bossie CA;Lindenmayer JP;Schooler N;Canuso CM;    Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis.  BMC Psychiatry.  2011;11:21      

Umbricht D;Schmid L;Koller R;Vollenweider FX;Hell D;Javitt DC;    Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.  Archives of General Psychiatry.  2000;57(12):1139-1147      

Urbanc B;Cruz L;Le R;Sanders J;Ashe KH;Duff K;Stanley HE;Irizarry MC;Hyman BT;    Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease.  Proceedings of the National Academy of Sciences of the United States of America.  2002;99(22):13990-13995      

Uzunov DP;Cooper TB;Costa E;Guidotti A;    Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography.  Proceedings of the National Academy of Sciences of the United States of America.  1996;93(22):12599-12604      

Vadasz C;Saito M;Gyetvai BM;Oros M;Szakall I;Kovacs KM;Prasad VV;Morahan G;Toth R;    Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains.  Neurochemical Research.  2007;32(7):1099-1112      

Vadasz C;Smiley JF;Figarsky K;Saito M;Toth R;Gyetvai BM;Oros M;Kovacs KK;Mohan P;Wang R;    Mesencephalic dopamine neuron number and tyrosine hydroxylase content: genetic control and candidate genes.  Neuroscience.  2007;149(3):561-572      

Veeranna;Kaji T;Boland B;Odrljin T;Mohan P;Basavarajappa BS;Peterhoff C;Cataldo A;Rudnicki A;Amin N;Li BS;Pant HC;Hungund BL;Arancio O;Nixon RA;    Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.  American Journal of Pathology.  2004;165(3):795-805      

Veeranna;Lee JH;Pareek TK;Jaffee H;Boland B;Vinod KY;Amin N;Kulkarni AB;Pant HC;Nixon RA;    Neurofilament tail phosphorylation: identity of the RT-97 phosphoepitope and regulation in neurons by cross-talk among proline-directed kinases.  Journal of Neurochemistry.  2008;107(1):35-49      

Vinod KY;Yalamanchili R;Thanos PK;Vadasz C;Cooper TB;Volkow ND;Hungund BL;    Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice.  Synapse.  2008;62(8):574-581      

Vitolo OV;Sant'Angelo A;Costanzo V;Battaglia F;Arancio O;Shelanski M;    Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling.  Proceedings of the National Academy of Sciences of the United States of America.  2002;99(20):13217-13221      

Volavka J;    Clozapine may be more effective than olanzapine for reducing suicidal behaviour in people with schizophrenia at high risk.  Evidence-Based Mental Health.  2003;6(3):93      

Volavka J;    Risk for individuals with schizophrenia who are living in the community [letter].  Psychiatric Services.  2002;53(4):484-485      

Volavka J;    The neurobiology of violence: an update.  Journal of Neuropsychiatry & Clinical Neurosciences.  1999;11(3):307-314      

Volavka J;Bilder RM;Lachman HM;    Genetic linkage for schizophrenia?.  American Journal of Psychiatry.  2004;161(6):1134-1135      

Volavka J;Citrome L;Huertas D;    Update on the biological treatment of aggression.  Actas Espa?olas de Psiquiatr?a.  2006;34(2):123-135      

Volavka J;Cooper TB;Laska EM;Meisner M;    Placebo washout in trials of antipsychotic drugs. [Review] [40 refs].  Schizophrenia Bulletin.  1996;22(4):567-576      

Volavka J;Czobor P;Lindenmayer JP;Citrome L;Mcevoy JP;Cooper TB;Lieberman JA;    Dr. Volavka and colleagues reply.  American Journal of Psychiatry.  2003;160(3):592-593      

Volavka J;Czobor P;Sheitman B;Lindenmayer JP;Citrome L;Mcevoy JP;Cooper TB;Chakos M;Lieberman JA;    Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder [erratum appears in Am J Psychiatry 2002 Dec;159(12):2132].  American Journal of Psychiatry.  2002;159(2):255-262      

Wang JH;Zuo XN;Gohel S;Milham MP;Biswal BB;He Y;    Graph theoretical analysis of functional brain networks: test-retest evaluation on short- and long-term resting-state functional MRI data.  PLoS ONE.  2011;6(7):e21976      

Ware NC;Hopper K;Tugenberg T;Dickey B;Fisher D;    Connectedness and citizenship: redefining social integration.  Psychiatric Services.  2007;58(4):469-474      

Ware NC;Hopper K;Tugenberg T;Dickey B;Fisher D;    A theory of social integration as quality of life.  Psychiatric Services.  2008;59(1):27-33      

Wesson DW;Levy E;Nixon RA;Wilson DA;    (non-copyrighted -attachment )
Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model.  Journal of Neuroscience.  2010;30(2):505-514      

Wesson DW;Verhagen JV;Wachowiak M;    Why sniff fast? The relationship between sniff frequency, odor discrimination, and receptor neuron activation in the rat.  Journal of Neurophysiology.  2009;101(2):1089-1102      

Wesson DW;Wilson DA;    (non-copyrighted -attachment )
Smelling sounds: olfactory-auditory sensory convergence in the olfactory tubercle.  Journal of Neuroscience.  2010;30(8):3013-3021      

Wesson DW;Wilson DA;Nixon RA;    (non-copyrighted -attachment )
Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?.  Expert Review of Neurotherapeutics.  2010;10(5):633-635      

Wilson DA;Chapuis J;Wesson DW;    Olfaction.  .  2010;:      

Wilson DA;Linster C;    Neurobiology of a simple memory.  Journal of Neurophysiology.  2008;100(1):2-7      

Wolfe BE;Metzger ED;Levine JM;Finkelstein DM;Cooper TB;Jimerson DC;    Serotonin function following remission from bulimia nervosa.  Neuropsychopharmacology.  2000;22(3):257-263      

Wolkin A;Choi SJ;Szilagyi S;Sanfilipo M;Rotrosen JP;Lim KO;    Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study.  American Journal of Psychiatry.  2003;160(3):572-574      

Wong TP;Debeir T;Duff K;Cuello AC;    Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.  Journal of Neuroscience.  1999;19(7):2706-2716      

Worden MS;Foxe JJ;    The dynamics of the spread of selective visual attention.  Proceedings of the National Academy of Sciences of the United States of America.  2003;100(21):11933-11935      

Worden MS;Foxe JJ;Wang N;Simpson GV;    Anticipatory biasing of visuospatial attention indexed by retinotopically specific alpha-bank electroencephalography increases over occipital cortex.  Journal of Neuroscience.  2000;20(RC63):1-6      

Wylie GR;Javitt DC;Foxe JJ;    Jumping the gun: is effective preparation contingent upon anticipatory activation in task-relevant neural circuitry?.  Cerebral Cortex.  2006;16(3):394-404      

Yang AJ;Chandswangbhuvana D;Shu T;Henschen A;Glabe CG;    Intracellular accumulation of insoluble, newly synthesized A beta n-42 in amyloid precursor protein-transfected cells that have been treated with A beta 1-42.  Journal of Biological Chemistry.  1999;274(29):20650-20656      

Yang DS;Kumar A;Stavrides P;Peterson J;Peterhoff CM;Pawlik M;Levy E;Cataldo AM;Nixon RA;    Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease.  American Journal of Pathology.  2008;173(3):665-681      

Yang DS;Tandon A;Chen F;Yu G;Yu H;Arawaka S;Hasegawa H;Duthie M;Schmidt S;Nixon RA;Ramabhadran TV;Mathews PM;Gandy SE;Mount HT;George-Hyslop P;Fraser PE;    Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins.  Journal of Biological Chemistry.  2002;277(31):28135-28142      

Yarmish G;Lipton ML;    Functional magnetic resonance imaging: from acquisition to application.  Einstein Journal of Biology and Medicine.  2003;20(1):2-9      

Yeap S;Kelly SP;Sehatpour P;Magno E;Javitt DC;Garavan H;Thakore JH;Foxe JJ;    Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives.  Archives of General Psychiatry.  2006;63(11):1180-1188      

Yu WH;Cuervo AM;Kumar A;Peterhoff CM;Schmidt SD;Lee JH;Mohan PS;Mercken M;Farmery MR;Tjernberg LO;Jiang Y;Duff K;Uchiyama Y;Naslund J;Mathews PM;Cataldo AM;Nixon RA;    Macroautophagy--a novel {beta}-amyloid peptide-generating pathway activated in Alzheimer's disease.  Journal of Cell Biology.  2005;171(1):87-98      

Yu WH;Fraser PE;    S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease.  Journal of Neuroscience.  2001;21(7):2240-2246      

Yuan A;Kumar A;Peterhoff C;Duff K;Nixon RA;    Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice.  Journal of Neuroscience.  2008;28(7):1682-1687      

Yuan A;Rao MV;Kumar A;Julien JP;Nixon RA;    Neurofilament transport in vivo minimally requires hetero-oligomer formation [Erratum in: J Neurosci. 2003 Nov 12;23(32):10463-5].  Journal of Neuroscience.  2003;23(28):9452-9458      

Yuan A;Rao MV;Sasaki T;Chen Y;Kumar A;Veeranna;Liem RK;Eyer J;Peterson AC;Julien JP;Nixon RA;    Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS.  Journal of Neuroscience.  2006;26(39):10006-10019      

Zheng YL;Li BS;Veeranna;Pant HC;    Phosphorylation of the head domain of neurofilament protein (NF-M): a factor regulating topographic phosphorylation of NF-M tail domain KSP sites in neurons.  Journal of Biological Chemistry.  2003;278(26):24026-24032      

Zheng ZH;Barkai AI;Hungund BL;    Effect of ganglioside GM1 on ethanol-induced changes in the incorporation of free fatty acids into membrane phospholipids in mouse brain.  Alcohol and Alcoholism.  1997;32(6):693-701      

Zimbroff DL;Allen MH;Battaglia J;Citrome L;Fishkind A;Francis A;Herr DL;Hughes D;Martel M;Preval H;Ross R;    Best clinical practice with ziprasidone IM: update after 2 years of experience.  CNS Spectrums.  2005;10(9):1-15      

Zimbroff DL;Kane JM;Tamminga CA;Daniel DG;Mack RJ;Wozniak PJ;Sebree TB;Wallin BA;Kashkin KB;Adan F;Ainslie G;Allan E;Atri P;Baker R;Beitman B;Brown G;Canive J;Carman J;Dott S;Edwards J;Fenton W;Freidli J;Funderburg L;Ereshefsky L;Gladson M;Hamilton J;Haque S;Hartford J;Horne R;Houck C;Jampala C;Labelle A;Larson G;Lesem M;Liskow B;Makela E;Moore N;Morphy M;Posever T;Risch S;Rotrosen J;Sheehan D;Silverstone P;Swann A;Tapp A;Thomas M;Volavka J;Vora S;    Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia.  American Journal of Psychiatry.  1997;154(6):782-791      

Ziwich RT;Olang C;Epstein H;Citrome L;    Horticultural therapy [letter].  Primary Psychiatry.  2008;15(10):24